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Chapter 1:  Introduction 
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Chronic rhinosinusitis: epidemiology, etiology, and treatment 
Epidemiology 
 Rhinosinusitis (RS) is an inflammatory syndrome affecting 6-15% of the general 
population (Fokkens et al., 2020; National Center for Health Statistics, 2019). RS 
encompasses a wide range of sinonasal symptoms including nasal congestion or discharge, 
facial pain or pressure, loss of the sense of smell, polyposis, mucopurulent discharge, and 
edema or obstruction of the sinuses and nasal cavity (Fokkens et al., 2020; Orlandi et al., 
2016). Chronic rhinosinusitis (CRS) is the persistence of symptoms beyond 12 weeks and 
has a prevalence of 5% of the general population (Hoggard et al., 2017). The costs of CRS 
are substantial at the individual and population levels (Bhattacharyya, 2011). This 
debilitating disease causes a significant decline in quality of life, including a reduction in 
physical wellbeing, and loss of the ability to work (Fokkens et al., 2020; Orlandi et al., 
2016). Individuals with CRS experience a significantly greater number of primary care 
visits compared to the general population (Bhattacharyya, 2011). The estimated economic 
burden of CRS in the United States to be $22 billion USD in direct and indirect costs, 
translating to $8,200-$10,500 per patient (Smith et al., 2015). 
Etiology 
 Although CRS has been researched for decades, its etiology remains unclear. Early 
studies favored an infection model of disease, whereby a pathogenic microorganism is 
causal to CRS. Until recently, the sinuses were considered sterile, and any presence of 
microorganisms to be pathogenic (Cook and Haber, 1987; Hamad et al., 2009; Sobin et al., 
2009). A 1981 study by Itzhak Brook was the first the document aerobic and anaerobic 
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microbiology in the healthy human sinuses. Since then, it is now accepted that microbial 
life exists in the upper respiratory tracts of individuals with and without respiratory disease. 
Additionally, the prevalence of canonical pathogens such as Staphylococcus aureus in the 
upper respiratory tract of up to 50% healthy individuals without any sinonasal symptoms 
has been confounding (Bassis et al., 2014; Gorwitz et al., 2008; Wertheim et al., 2005). 
More recently, hypotheses implicating genetic, atopic, and inflammatory processes in 
immune barrier dysfunction have become more prominent (Hoggard et al., 2017; Lam et 
al., 2015). The most inclusive models suggest both barrier disruption and microbial 
pathogenesis to be intertwined in the development of CRS, however mechanisms of host-
microbial feedback in the progression to a state of chronic inflammation have not been 
characterized. 
 Genetic susceptibility constitutes at least one basis for CRS development. Several 
syndromes with established genetic components have CRS as a clinical consequence, 
including primary ciliary dyskinesia, and cystic fibrosis (CF) (Hsu et al., 2013). It is 
estimated that 90% of people with CF have CRS, making it an important comorbidity to 
study in this population (Chaaban et al., 2013; Hamilos, 2016). Indeed, even carriers of 
mutations in the CFTR gene (whose gene product absence or dysfunction is responsible 
for CF) are at higher risk of CRS development (Wang et al., 2005), underlying the 
importance of homeostatic mechanisms maintaining barrier function at respiratory mucosal 
surfaces. Sinonasal pathogen colonization has been linked to lung infections that are the 
primary cause of most morbidity and mortality in the CF population, suggesting both 
microbial and inflammatory processes in the sinuses are integral to the health of a unified 
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airway (Illing and Woodworth, 2014). Chapters 2 and 3 of this dissertation focus on CF-
associated CRS, and explore the relationship between pulmonary and CRS microbiota. 
 Aside from genetic factors, the majority of hypotheses for CRS etiology focus on 
prolonged abnormal inflammatory response, responsiveness to treatments, and associated 
environmental stimuli such as allergens, toxins, and microorganisms. The most frequently 
used method for categorizing CRS is based on the presence or absence of nasal polyps, 
termed CRSwNP and CRSsNP, respectively (Fokkens et al., 2020). This is the context in 
which most current etiological theories are framed, however, there is no current 
explanation that completely supports the division of cases into these two subtypes. 
Regardless, obstruction of the upper airway passages is universal to both CRSwNP and 
CRSsNP. 
 Efforts to define disease “endotypes” consider the additional involvement of 
immune barrier dysfunction in CRS (Fokkens et al., 2020; Lam et al., 2015). Defects in 
physical properties of the mucosal layer, mucociliary clearance, antimicrobial peptide 
production and cell surface receptor function, and integrity of epithelial cell tight junctions 
are considered in this model, and it is most inclusive to CRSwNP and CRSsNP. Allergy 
and atopic disease may likely constitute another disease endotype, however the association 
is still poorly defined (Marcus et al., 2019). 
 Finally, there is consensus that bacterial infection is an integral component to 
pathogenesis in CRS. It is still unclear whether the dysfunctional inflammatory response, 
sinus blockage, and reduced mucociliary clearance in CRS result in, or are caused by shifts 
in sinus bacteria. Current hypotheses include single pathogen virulence (e.g. 
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Staphylococcus aureus superantigen expression), bacterial biofilm formation, and 
microbiome dysbiosis (Foreman et al., 2011; Hoggard, Biswas, et al., 2017; Ou et al., 
2014). It is likely the development of CRS is multifactorial, involving both infection and 
host-inflammatory components. 
Treatment 
 Antibiotics are a mainstay of rhinosinusitis (RS) treatment. In a five-year study, 
antibiotics were prescribed in 80% of all outpatient visits with a diagnosis of RS, and 50% 
of CRS visits (S. Smith et al., 2013). During that period RS/CRS made up 11% of all adult 
clinic visits resulting in an antibiotic prescription, the highest of any other measured 
diagnosis (S. Smith et al., 2013). These data are remarkable, because a number of medical 
consensus reports do not recommend antibiotics as part of standard clinical care for RS 
(Fokkens et al., 2020; Orlandi et al., 2016), and the use of antibiotics in CRS is 
controversial (Hoggard, Mackenzie, et al., 2017). Several clinical trials have shown limited 
evidence for the efficacy of antibiotics in the treatment of CRS. One review found that 
antibiotics benefitted the patient only when prescribed post-surgery (Lim et al., 2008). 
Other studies have shown antibiotics improve patient outcomes only in culture-directed 
scenarios where a known antibiotic-susceptible pathogen was identified, and symptoms 
such as purulent secretions, site pain, and fever point to acute bacterial infection (Huang 
and Govindaraj, 2013; Lim et al., 2008). Hypotheses for reduced efficacy of antibiotic 
treatment in CRS include inflammation-mediated blockage of the sinuses - reducing access 
to the infection site, polymicrobial biofilm formation, and antibiotic resistance mechanisms 
(Kennedy and Borish, 2013).  
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 In contrast to current recommendations for antibiotic treatment of CRS, there is 
evidence for the efficacy of treatments that reduce inflammation and relieve sinonasal 
blockage. Topical steroids and hypertonic saline rinses have both been associated with CRS 
symptom relief (Huang and Govindaraj, 2013; Rudmik et al., 2012). Functional endoscopic 
sinus surgery (FESS) employed to remove polyps, physically debride the sinuses, and open 
up the sinonasal cavity has also been shown to have largely positive outcomes for CRS 
patients who have failed prior medical interventions (Chester et al., 2008). The higher rates 
of effectiveness of these treatments underscores the convergence of etiological hypotheses 
on sinus blockage and inflammation as major drivers of this disease.  
 The high prevalence and heterogeneity of CRS call for the development of new 
treatments. One concern is the contribution of antibiotic use for RS and CRS to the global 
public health issue of antibiotic resistance, however clinical perspectives on antibiotic use 
for the treatment of RS and CRS are beginning to change (Essack and Pignatari, 2013; 
Kennedy and Borish, 2013). Although more proven, FESS is an invasive procedure, and 
between 17-25% of CRS patients will require further surgical treatment within 10 years of 
undergoing FESS (T. L. Smith et al., 2019). This thesis presents an improved 
understanding of the microbial ecology in CRS, which may guide the development of more 
strategic treatment of pathogenic bacteria in CRS. 
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Bacteriology of Chronic Rhinosinusitis 
The Bacterial contribution to CRS 
 Unifying all potential causes of CRS is the resulting mucus stasis, which contrasts 
the constant movement of mucus out of the healthy respiratory system. Mucociliary 
clearance, facilitated by the synchronized beating of cilia lining the pseudostratified 
epithelium of the airways, allows the constant movement of particulates - including 
microorganisms - to be shuttled out of the airways. In CRS, this process becomes 
dysfunctional, leading to microenvrionmental perturbations that both impact and are 
potentially influenced by microorganisms present in this niche. Bacterial proliferation and 
virulence, polymicrobial biofilm formation, or changes in the diversity of bacteria 
(presence and abundance), are all considered potential pathogenic mechanisms in CRS that 
are not mutually exclusive (Hoggard, Mackenzie, et al., 2017). While the bacteriology of 
healthy and CRS sinuses is increasingly well described, the role of bacteria in CRS 
pathogenesis remains unclear, and our ability to understand the disease is constrained when 
observations are limited to a single timepoint in a cross-sectional study design. 
 
Early culture work 
 Early culture-based studies contextualized any bacterial presence in the sinuses to 
be pathogenic, and often focused on the recovery and in vitro characterization of a 
causative pathogenic organism. Bacteria commonly recovered in these studies included 
Staphylococcus aureus, Moraxella spp., Haemophilus influenzae, and Pseudomonas 
aeruginosa (Hoggard, Mackenzie, et al., 2017). These organisms remain the most 
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frequently identified pathogens in CRS by culture, however, numerous culture-based 
surveys have expanded our knowledge of sinus-associated bacteria to include more 
members of the aerobic and facultative anaerobic genera Staphylococcus, Haemophilus, 
Pseudomonas, Streptococcus, and Corynebacterium (Bhattacharyya and Kepnes, 1999; 
Brown et al., 1998; Finegold et al., 2002; Hauser et al., 2015; Kaspar et al., 2015; Nadel et 
al., 1998). A study by Kaspar et al. found 139 different bacterial species in a cohort of 16 
non-CRS and 18 CRS patients, and showed Streptococcus epidermidis, S. aureus, 
Propionibacterium acnes, Propionibacterium avidum, Propionibacterium granulosum, 
Corynebacterium accolens, Corynebacterium tuberculostearicum, and Finegoldia magna, 
comprised the most frequently isolated organisms, regardless of disease state (Kaspar et 
al., 2015). The greatest diversity was seen in the genus Corynebacterium, with 23 different 
species identified. The study stressed a lack of bacterial identification associated with CRS 
status, and confirmed high inter-subject variability seen in other studies. Indeed, 
asymptomatic prevalence of S. aureus in the sinonasal cavity of adults is estimated ~50% 
(Bassis et al., 2014; Gorwitz et al., 2008; Wertheim et al., 2005). Occurrence of these 
organisms in both healthy and CRS subjects suggests that the potential for virulence of any 
single organism depends on factors controlled by the infection microenvironment such as 
available nutrients and co-colonizing organisms. These parameters are difficult to 
approximate in vitro. 
 In an effort to describe bacteriology unique to CRS, a hypothesis emerged that 
anaerobic bacteria were prevalent and associated with pathogenesis. Besides the 
recognized inflammation and reduction in mucociliary clearance, characterization of the 
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physical and chemical aspects of the CRS sinus environment, including oxygen 
consumption by aerobic organisms and innate immune cells, hypoxia-induced mucus 
hypersecretion, and increased sinus pressure, support the idea that the CRS sinuses provide 
a low-oxygen niche for anaerobe proliferation. The association of anaerobes with chronic 
infections is not unprecedented and has been described at other epithelial sites. For 
example, Flynn et al. demonstrated mucin-degrading consortia can be isolated from CF 
sputum, and mucin-degradation byproducts can augment growth of P. aeruginosa (Flynn 
et al., 2016). Additionally, in chronic wounds, anaerobe co-occurrence with common 
wound pathogens such as S. aureus has also been described (Choi et al., 2018; Wolcott et 
al., 2016). 
 Several studies support a role for anaerobic bacteria in CRS. In a 2011 review, 18 
studies using culture-based techniques found that anaerobes comprised 8-93% of isolates 
from 32-100% of patients tested (Brook, 2011). Variability in recovery may be the result 
of differences in sampling and/or culture technique, but also may indicate that the presence 
of anaerobic bacteria may have a temporal relationship with CRS disease progression. In 
one of the only longitudinal microbiology surveys of CRS to date, Brook and colleagues 
evaluated sinus aspirates in five patients with repeated failures of antibiotic management 
over the course of 34-50 days, nearing the threshold for defined chronic disease (12 weeks) 
(I Brook et al., 1996). Results suggested that failure to respond to antibiotic therapy was 
associated with the presence of antibiotic resistant aerobic bacteria, and the emergence of 
Fusobacterium nucleatum, pigmented Prevotella, Porphyromonas spp., and 
Peptostreptococcus spp. in the subsequent aspirate. Symptoms in these patients were only 
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resolved through the administration of an antibiotic cocktail with activity against these 
organisms, or surgical sinus drainage. In one of the most detailed studies of the diversity 
of anaerobic organisms in CRS, Finegold and colleagues found that while antibiotic 
treatment failure was more associated with aerobic bacteria S. aureus and P. aeruginosa, 
the recurrence of CRS symptoms after successful treatment were twice as frequent when 
anaerobes were present at greater than 103 colony forming units (Finegold et al., 2002). 
Interestingly, Brook and Frazier found that anaerobes were associated with CRS patients 
who had not had previous sinus surgery (Itzhak Brook and Frazier, 2001). Taken together, 
these results suggest that selective pressures exist in the establishment of CRS that promote 
growth of anaerobic bacteria. Without surgical management anaerobes may establish 
synergistic polymicrobial communities that become difficult to eradicate.  
 Similar to the aerobic culture results, differential identification of anaerobes 
associated with CRS is still confounded by their regular isolation from non-CRS sinuses. 
Kasper et al. described isolation of species from Finegoldia, Fusobacterium, Prevotella, 
Veillonella, Anaerococcus, Parvimonas, Clostridium, and Peptoniphilus from the sinuses 
regardless of CRS status (Kaspar et al., 2015). The high similarity of bacterial taxa found 
in both CRS and non-CRS sinuses calls for new approaches to determine their pathogenic 
contribution of bacteria in this niche. 
 
The Sequencing Perspective 
 Clinical culture remains the gold standard for pathogen identification and guidance 
of antibiotic administration in sinusitis cases, however, clinical cultures fail to grow 
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bacteria in up to 45% of CRS cases, suggesting that cultivability is a barrier to bacterial 
identification (Hauser et al., 2015; Mantovani et al., 2010). Use of culture-independent 
methods that depend on nucleic acids for identification of microorganisms relieves the 
culture constraint and is demonstrably better at capturing bacterial diversity among human-
associated microbiota. A frequently used method of molecular identification is targeted 
sequencing of the variable regions of the 16S rRNA gene, which are able to 
phylogenetically differentiate bacteria. In CRS, 16S rRNA gene sequencing (16S) 
identifies up to an order of magnitude greater bacterial taxa compared to culture alone 
(Bassiouni et al., 2015; Hauser et al., 2015; Ramakrishnan et al., 2015). Even in the 
ambitious culture-based study by Kasper et al., 16S recovered more unique bacterial taxa, 
albeit species resolution was accomplished less often. This increased ability to identify 
bacteria in the CRS niche allows for better approximation of bacterial diversity.  
 In agreement with culture-based studies, 16S surveys demonstrate high interpatient 
variability in microbial community composition and identify the most prevalent genera in 
sinus communities regardless of disease status are Staphylococcus, Corynebacterium, and 
Propionibacterium. Without the constraint of cultivation, detection of anaerobic bacteria 
in the sinuses is common in molecular surveys and are detected in both CRS and non-CRS 
samples (Hoggard, Mackenzie, et al., 2017). Despite many attempts at using these high-
resolution techniques to compare CRS to non-CRS microbiota, no strong patterns have 
emerged. When 16S genes are quantitated, there is no significant difference in gene copy 
number between CRS and non-CRS subjects, suggesting that increased bacterial load 
cannot explain pathogenesis completely in CRS. Several studies have shown that sinus 
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bacterial communities demonstrate a spectrum of diversity with CRS microbiota generally 
considered to be less diverse than non-CRS, however the significance of this comparison 
varies (Abreu et al., 2012; Biswas et al., 2015; Feazel et al., 2012; Ramakrishnan et al., 
2015). In two separate studies, Ramakrishnan et al. found lower diversity communities to 
be associated with comorbidities asthma and purulent sinus secretions, while cigarette 
smoking was associated with lower diversity in both non-CRS and CRS subjects. 
Furthermore, patients whose samples exhibited higher bacterial diversity had better 
outcomes after surgery (Ramakrishnan et al., 2015; Ramakrishnan and Frank, 2015). 
Currently, the description of bacterial diversity has had limited value in differentiating the 
bacterial communities of CRS from non-CRS. These data indicate, however, that use of 
patient clinical parameters, coupled with longitudinal sampling and larger cohorts are 
promising ways of stratifying CRS disease for more informative diversity comparisons. 
 Molecular surveys have also been used to identify associations of individual 
organisms with CRS. Abreu et al. used the 16S-based PhyloChip approach to show 
increased relative abundance of Corynebacterium tuberculostearicum in CRS. 
Importantly, this is the only study of CRS microbiota to corroborate their findings in vivo. 
In a murine model of CRS, C. tuberculostearicum inoculation in animals with antibiotic-
depleted sinus microbiota exhibited goblet cell hyperplasia - a common indicator of sinus 
pathology (Abreu et al., 2012). In contrast, another study found C. tuberculostearicum to 
be associated with better FESS outcomes and milder disease compared to S. aureus 
(Ramakrishnan et al., 2015). In a study by Cope et al., samples clustered into subgroups 
based on the dominance of either Streptococcaceae, Pseudomonadaceae, 
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Corynebacteriaceae, or Staphylococcaceae, with non-CRS subjects only appearing in 
clusters dominated by Streptococcaceae and Corynebacteriaceae (Cope et al., 2017). 
Interestingly, several studies have now demonstrated a reciprocal relationship between S. 
aureus and Corynebacterium spp. abundance, and antagonistic interactions in vitro (Lina 
et al., 2003; Mackenzie et al., 2017; Ramsey et al., 2016; Yan et al., 2013). Pathogenic 
mechanisms may not be revealed through bacterial identification alone.  
 Given the results of both culture-dependent and independent surveys, it is apparent 
that the contribution of sinus microbiota to chronic disease is complicated. The high 
variability seen in CRS necessitates stratification of the disease in clinically meaningful 
ways. To this end, Chapters 1 and 2 contribute much needed molecular surveys of sinus 
and lung microbiota in CF-specific CRS. Conclusions made from recent studies discussed 
in this section are (a) the mere detection of a suspected pathogenic bacterium in the sinuses 
is not necessarily associated with disease, and (b) high interpatient variability in both health 
and disease. These conclusions serve to point research objectives in a new direction that 
explores ecological parameters of the CRS microenvironment. These include bacterial 
community facilitated functions that may loosely be related to taxonomy but have a large 
impact on disease. 
  
 14 
New hypotheses: Mucin-microbe interactions in CRS 
 Mucus is a viscous secreted gel matrix that coats many epithelial surfaces in the 
body. In the healthy human respiratory tract, mucus sits on top of a periciliary fluid layer 
and is in constant motion across the pseudostratified epithelium, propelled by coordinated 
ciliary beat function. Mucus serves several roles for maintaining homeostasis including 
maintaining hydration and carrying out innate immune barrier functions. Despite its major 
role in protecting the epithelium, respiratory mucus is also the site of dense microbial life. 
Mucus-mediated mechanisms involved in microbial pathogenesis have been investigated 
for decades, yet our understanding of this dynamic relationship is still evolving. 
 There are at least three mucus-related processes that occur in CRS. First is goblet 
cell hyperplasia, or increased development of mucus secreting cells in the sinus epithelium 
(Majima et al., 1997; Petruson, 1994; Tos and Mogensen, 1984). Second is increased 
mucus production observed both in expression-based studies, and patient symptom 
presentation (Ding and Zheng, 2007; Kim et al., 2004). Third is the slowing of mucus 
clearance, mediated by reduced ciliary beat and inflammatory swelling (Stevens et al., 
2015). Based on these mechanisms, static mucus becomes a dominant component of the 
CRS microenvironment. 
 The major components of mucus are mucins - glycoproteins that are heavily 
decorated with O-linked glycans attached to tandem repeating elements rich in proline, 
serine and/or threonine residues. N- and C- termini are cysteine-rich regions important for 
its multimeric gel-forming properties (Wagner et al., 2018). By weight, glycans make up 
80% of the mass of these molecules (Bansil and Turner, 2006). The complex and diverse 
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glycan structures scaffolded on protein backbones are composed primarily of five 
monosaccharides (galactose, N-acetylglucosamine (GlcNAc), N-acetylgalactosamine 
(GalNAc), fucose, sialic acid) (Bansil and Turner, 2006). Mucin glycoproteins produced 
in the respiratory tract include MUC5B, MUC5AC, MUC1, MUC4, and MUC16 (Zanin et 
al., 2016). 
 Mucins have several functions with implications for microbial ecology and 
virulence potential. The immense diversity of glycan structures on mucins have been 
appreciated as cues for microbial metabolism, virulence, interbacterial interaction, and 
aggregation (Wagner et al., 2018). The oligomerization of mucins results in a physical 
matrix that creates nutrient and oxygen gradients which are hypothesized to be important 
for spatial niche partitioning and stable assembly of multi-species in the gastrointestinal 
tract (Wagner et al., 2018). Finally, mucins can act as a nutrient source to those 
microorganisms with specialized enzymes to degrade them (Bradshaw et al., 1994; Derrien 
and Passel, 2010; Hoeven and Camp, 1991; Wickström et al., 2009). Most microorganisms 
do not have the enzymatic repertoire to completely degrade a mucin glycoprotein, 
therefore, mucin as a nutrient source is thought to promote metabolically stable 
communities with diverse enzymatic functions that act to competitively exclude less well 
adapted organisms. The ecological function of competitive exclusion is often seen as a 
positive outcome of stability of mucin-utilizing communities in the gut and oral cavity 
(Bergstrom and Xia, 2013; Buffie and Pamer, 2013; Hibbing et al., 2010; Malago, 2015). 
Alternatively, this stability may contribute to chronic infection in the sinuses by reducing 
therapeutic effectiveness and producing metabolites and chemical signals that may 
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potentiate virulence in commensal microorganisms. In Chapter 4, we predict the presence 
of anaerobic mucin-degrading communities in CRS sinus mucus, show their presence in in 
vitro enrichment experiments, and demonstrate their ability to alter S. aureus growth and 
transcription. 
 Taken together, mucin glycoproteins likely influence many aspects of microbial 
behavior seen in the sinuses. This thesis presents a novel investigation into bacterial mucin 
degradation with respect to CRS pathogenesis. 
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Chapter 2:  16S rRNA gene sequencing reveals site-specific signatures of the upper 


















† Reprinted from Journal of Cystic Fibrosis. Sarah K. Lucas, Robert Yang, Jordan M. 
Dunitz, Holly C. Boyer, and Ryan C. Hunter. “16S rRNA gene sequencing reveals site-
specific signatures of the upper and lower airways of cystic fibrosis patients.” © 
European Cystic Fibrosis Society. Originally published by Elsevier B.V. in Journal 




 Metastasis of sinus microbiota in cystic fibrosis (CF) patients may have significant 
implications in the development of chronic lung disease. Here, we compare bacterial 
communities of matched sinus and lung mucus samples from CF subjects undergoing 
endoscopic surgery for treatment of chronic sinusitis. Mucus was isolated from the sinuses 
and lungs of twelve patients. 16S rRNA gene sequencing was then performed to compare 
the structure and function of CF airway microbiota. Bacterial richness was comparable 
between airway sites, though the sinuses harbored a higher prevalence of dominant 
microorganisms. Ordination analyses revealed that samples clustered more consistently by 
airway niche rather than by individual. Finally, predicted metagenomes suggested that 
anaerobiosis was enriched in the lung environment. Our findings indicate that while the 
paranasal sinuses and lungs may comprise a unified airway in which the lungs are seeded 





Defective CFTR ion transport at the sinus epithelium leads to decreased 
mucociliary clearance and obstruction of sinus ostia (Robertson et al., 2008). Secondary 
events such as the impairment of host defenses render this niche susceptible to bacterial 
colonization and chronic rhinosinusitis (CRS) (Becker, 2010; Robertson et al., 2008). 
Notably, there is a striking incidence of CRS in the CF population relative to non-CF 
subjects (~16% (Babinski and Trawinska-Bartnicka, 2008)). This is particularly evident in 
CF patients with classical mutations (class I-III), who, based on radiological evidence, have 
a CRS incidence rate of nearly 100% (Robertson et al., 2008).  
Culture-based studies have revealed that CF-associated CRS (CF-CRS) patients 
harbor distinct microbiota, including Staphylococcus aureus and Haemophilus influenzae 
in pediatric patients, followed by Pseudomonas aeruginosa and other pathogens as patients 
age (Roby et al., 2008). This dynamic generally follows the same succession of CF lung 
microbiota (Cox et al., 2010) and several groups have demonstrated similarities in upper 
and lower airway bacteriology in CF subjects (Bonestroo et al., 2010; Fischer et al., 2014). 
In fact, evidence has implicated the sinuses as infection foci for lung pathogens, where they 
first adapt to the host before descending into the lungs (Ciofu et al., 2013; Hansen et al., 
2012; Johansen et al., 2012; Mainz et al., 2009, 2012; Rudkjøbing et al., 2014; Syed et al., 
2016). Genotypic analyses suggest a direct exchange between sites; P. aeruginosa isolates 
cultured simultaneously from the sinuses and lungs were genetically identical in 38 of 40 
subjects (Johansen et al., 2012). These data are supported by studies of CF lung transplants, 
where recipient allografts were re-colonized by the same P. aeruginosa clones found prior 
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to transplantation (Ciofu et al., 2013; Syed et al., 2016). Altogether, these observations 
support the notion of a sinus pathogen reservoir and a unified airway, in which the 
treatment of CRS could have profound benefits for CF lung disease management. 
While P. aeruginosa and S. aureus are commonly isolated from the CF sinuses 
(Mainz et al., 2009), culture-independent studies also suggest colonization by anaerobes 
(e.g. Cutibacterium) and other non-canonical pathogens (Rudkjøbing et al., 2014). These 
data are consistent with microbiome profiles of CF lung disease, which is recognized to 
have a polymicrobial etiology (Coburn et al., 2015; Cox et al., 2010). Recent sequencing 
studies have evaluated relationships between oral, nasal and lung microbiota in adult CF 
patients (Boutin et al., 2015; Caldas and Boisramé, 2015), but to our knowledge, molecular 
approaches have not been used to assess relationships between sinuses and lungs at a 
microbial community level. From a clinical perspective, these data could be of considerable 
therapeutic benefit; sinus culture can be invasive and time consuming, and to date, sputum 
culture-guided therapies for CRS have been largely ineffective, with many subjects 
ultimately requiring surgical intervention (Lavin et al., 2013; Osborn et al., 2011). 
Therefore, a deeper understanding of microbiological relationships between the sinuses 
and lungs may not only improve upon CF-CRS management, but may also motivate the 
use of less-invasive sinonasal sampling to help inform patient therapy (Fischer et al., 2014; 
Mainz et al., 2009; Mainz and Koitschev, 2012). 
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Materials and Methods 
Patient cohort and specimen collection 
 Twelve participants with CF undergoing functional endoscopic sinus surgery 
(FESS) were recruited at the University of Minnesota Department of Otolaryngology. 
Informed consent was obtained from all subjects. Prior to FESS, each patient spit to discard 
saliva, followed by sputum expectoration into a collection tube. All samples were assessed 
macroscopically for salivary contamination, and none were rejected. Sinus secretions were 
obtained from a single maxillary sinus (middle meatal region) under endoscopic 
visualization by suction into mucus traps (Cardinal Health, Dublin, OH). Clinical data were 
also obtained (Table S1, Appendix A), including CFTR genotype, FESS procedures, 
clinical cultures, spirometry (FEV1%) and sinonasal outcome test (SNOT-22) scores. The 
UMN Institutional Review Board approved these studies (#1403M49021).  
 
Quantitative PCR 
Bacterial burden was estimated by quantifying 16S copy number from DNA 
extracted from clinical specimens using quantitative PCR. Reactions were prepared in 
triplicate using QuantiTect SYBR Green (Qiagen) and Universal 16S rRNA qPCR primers 
(Abreu et al., 2012). Details can be found in the supplemental data (Appendix A).  
 
DNA sequencing and analysis 
 Genomic DNA was extracted from 300 μL of mucus using Powersoil Kits (MoBio, 
Carlsbad, CA) and was submitted to the UMN Genomics Center (UMGC) for 16S library 
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preparation using a two-step PCR protocol (Gohl et al., 2016). The V4 region was 
amplified and sequenced using Illumina MiSeq TruSeq 2 × 300 paired-end technology. 
Water and reagent control samples were also submitted but were below detection 
thresholds. Raw sequence files were deposited in the NCBI Sequence Read Archive 
(accession #PRJNA374847). Data were analyzed using a pipeline developed by the UMN 
Informatics Institute in collaboration with UMGC. Details are provided in the supplemental 
data (Appendix A). 
 
Metagenomic prediction 
Metagenomes were inferred from 16S rRNA data using Phylogenetic Investigation 
of Communities by Reconstruction of Unobserved States (PICRUSt) (Langille et al., 
2013). PICRUSt uses marker gene survey data to predict metagenome content through 
ancestral state reconstruction of quality-filtered 16S sequence data. We also used BugBase 
(Ward et al., 2017) to summarize predicted metagenomes by bacterial phenotype. BugBase 
scripts were run with default settings using filtered sequence data used in PICRUSt. Details 
are provided in the supplemental data (Appendix A). 
 
Statistical analyses 
Analyses were performed in GraphPad Prism 6.0 unless stated otherwise. Significance was 
assessed at the α = 0.05 level. Hypothesis testing was conducted assuming a paired sample 
study design. Student's t-tests were used where data passed the Kolmogorov-Smirnov test 
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for normality. Statistics implemented in beta diversity and BugBase analyses are 





Twelve CF adults with CRS undergoing functional endoscopic sinus surgery 
(FESS) each provided an expectorated sputum sample. Sinus mucus was collected at the 
beginning of FESS. These samples are herein referred to as “sinus” and “lung” samples, 
denoting their anatomical origin. Clinical data, including CF genotype, microbiology 
cultures, prior FESS procedures, spirometry and sino-nasal outcome test (SNOT-22) scores 
were also collected (Table S1, Appendix A). Six patients were homozygous ΔF508, five 
were heterozygous ΔF508, and two had heterozygous non-ΔF508 mutations. Sinus culture 
data were available for 11 of 12 sinus samples. Of these, 6 were positive for P. aeruginosa, 
and 5 were positive for S. aureus. Predominant lung pathogens detected by sputum culture 
were also recorded (Table S2, Appendix A). 
 
Bacterial load in sinus and lung samples 
qPCR of 16S ribosomal RNA (rRNA) gene copy number was used to estimate bacterial 
load (Figure 2.1). On average, sinus specimens contained 2.72 × 103 (IQR = 2.69 × 102 − 
1.72 × 103) 16S gene copies per ng genomic DNA, while lung sputum harbored 5.33 × 104 
(IQR = 6.18 × 102 − 5.02 × 104). These data suggest a modest difference in 16S gene 
abundance between sample types (Figure 2.1A, P = 0.0637). Interestingly, patient age was 
positively associated with 16S gene abundance in sinus samples, but this relationship was 
not observed for the lung (Figure 2.1B). We also assessed the relationship between 
bacterial load and two clinical metrics, FEV1% and SNOT-22, neither of which 
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significantly correlated with 16S copy number in either sample group (Figure 2.1B). Taken 
together, these data suggest that the specific composition of each bacterial community 
rather than bacterial abundance contributes to disease states in both sinus and lung niches. 
 
Bacterial community membership varies with location 
Bacterial composition was profiled using 16S rRNA gene sequencing. After 
filtering for quality and subsampling to an even depth, 51 genera were identified across 
samples (Figure 2.2). To investigate genera that accounted for the majority of sequences, 
we adopted the definition of a dominant genus (the most abundant genus with over twice 
the abundance of the second most abundant genus) (Coburn et al., 2015). A dominant genus 
was present in 100% of sinus samples but only 33% of lung samples. Pseudomonas and 
Staphylococcus were dominant genera in five sinus samples each (42%), while 
Streptococcus and Burkholderia were each dominant in a single sample (Figure 2). As 
expected, only P. aeruginosa and S. aureus were dominant lung pathogens. Species-level 
identification for abundant pathogens was determined by culture data, when available 
(Table S2, Appendix A). The median relative abundance of the predominant genus was 
0.88 (IQR = 0.75–0.99) in each sinus sample, and 0.42 (IQR = 0.34–0.78) for lung samples. 
The most abundant sinus OTUs were assigned to Pseudomonas, Staphylococcus, and 
Streptococcus. By contrast, lung samples harbored an abundance of Pseudomonas, 
Veillonella, and Prevotella, consistent with previous studies (Coburn et al., 2015; Cox et 
al., 2010). Interestingly, although many taxa were shared between sample pairs, the 
absence of a pathogen (e.g. Pseudomonas, Achromobacter) in one sample was not 
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predictive of its absence in its paired sample sequence data. For example, subjects 5 and 
12 harbored Achromobacter in their upper airways, despite being undetectable in sputum. 
This was also true of Staphylococcus in subject 6. Conversely, subjects 1 and 11 harbored 
an abundance of known CF pathogens (Pseudomonas and Haemophilus, respectively) in 
the lung that were not associated with upper airway infection. These examples demonstrate 
that infections at either site can be perpetuated by different pathogen within an individual, 
and that sputum cultures and 16S rRNA sequence data are not always representative of 
upper airway infection. 
Based on these examples, we then determined the extent to which genera were 
shared between sites. Spearman correlations between genera in matched pairs revealed that 
within-patient similarities allowed for significant positive correlation between sites in ten 
of twelve sample pairs (average Spearman ρ = 0.45) (Table S3, Appendix A). However, a 
group-wise comparison of paired samples showed a weaker correlation (Spearman ρ = 
0.32, P = 0.001). These results highlight the potential for bacterial communities of the 
upper and lower airways to be similar within a given patient, yet the group correlation 
underlines the general dissimilarity in microbiota between sinus and lung 
microenvironment. 
 
Bacterial diversity varies between upper and lower airways 
As described above, few taxa dominated most sequences in each sample. To 
investigate this further, two alpha diversity metrics, observed operational taxonomic units 
(OTUs) and Shannon diversity, were used as measures of richness (biodiversity) and 
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evenness (equitability) (Hill, 1973). Observed OTUs in lung samples were greater than in 
sinuses, indicating greater richness, though the difference was not significant (Figure 
2.3A). Using the Shannon diversity index, sinuses were characterized by greater 
unevenness relative to lung samples, consistent with the high prevalence of dominant sinus 
genera (Figure 2.3B). When ordered by rank, an average of 10 and 20 genera accounted 
for 99% of sequences in sinus and lung samples, respectively (Figure 2.3C). These data 
indicate that the lung bacterial community is greater in both richness and evenness relative 
to the sinuses.  
Spearman correlations were then calculated to assess relationships between 
bacterial load, alpha diversity and patient clinical data (Figure 2.3D). These data revealed 
a significant inverse correlation between Shannon diversity in the sinus and lung (ρ = − 
0.664, P = 0.022). Because the data show a similar richness between sites, and both sinus 
and lung Shannon diversity revealed positive relationships with observed OTUs (sinus ρ = 
0.881, P = 3.35 × 10−4; lung, ρ = 0.774, P = 0.007), we infer that diversity differences are 
driven by evenness in these niches. Lung Shannon diversity was also positively correlated 
with lung 16S rRNA copy number (ρ = 0.678, P = 0.019), and these data reiterate the 
positive correlation between sinus 16S rRNA gene copy number and patient age (ρ = 0.624, 
P = 0.033; Figure 2.1B). There was no correlation found between alpha diversity metrics, 
or relative abundance of Staphylococcus/Pseudomonas and antibiotics prescribed three 
days prior to surgery for both sample types (Table S4, Appendix A). Altogether, these 
results demonstrate that bacterial diversity differs between sinus and lung niches, and that 
a decrease in diversity at either site is associated with the decrease in even distribution of 
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bacterial taxa. 
Airway location as a descriptor of phylogenetic variance.  
 Beta diversity of airway microbiota was then visualized using ordination. Of 
interest was whether bacterial communities would cluster more closely by patient or 
sampling site. Previous studies characterizing upper and lower airway microbiota revealed 
shared taxa between sites, but also inter-individual variation (Boutin et al., 2015; Charlson 
et al., 2011; Fischer et al., 2014). Evidence also suggests that bacterial metastasis between 
the sinuses and lung is commonplace (Mainz et al., 2009). Based on these previous studies, 
we hypothesized that samples would cluster more closely by patient, rather than by 
sampling site. To address this hypothesis, we compared samples utilizing weighted 
Unifrac, an abundance-sensitive, phylogenetically relevant diversity metric (Lozupone and 
Knight, 2005). This metric was calculated to determine phylogenetic pairwise distances 
between each sample, then plotted using principal coordinates analysis (PCoA). Contrary 
to our hypothesis, within-patient sample pairs did not cluster together nearly as strongly as 
they did by sampling site (Figure 2.4A), which rejected the null hypothesis the groupings 
(sinuses and lungs) had the same centroid (PERMANOVA, P = 0.019). Lung samples also 
demonstrated considerable phylogenetic variation when compared to sinus samples (Figure 
2.4A). When relative abundances from dominant taxa (Pseudomonas and Staphylococcus) 
were overlaid, there was a strong association with the PCoA sample distribution (Figure 
2.4B). These analyses demonstrate that overall community structure is largely driven by 
dominant genera, and that upper and lower airways select for unique bacterial community 
structures, despite sharing individual taxa. 
 29 
Predicted metagenomes show phenotypic conservation between sites 
 To gain insight into bacterial community function, PICRUSt (Langille et al., 2013) 
was implemented to infer bacterial metagenomes based on 16S rRNA gene content. 
Sequences derived from each sample had a low Nearest Sequenced Taxon Index average 
of 0.017, indicating a high relatedness between bacteria found in the samples to sequenced 
genomes, and a high prediction accuracy for the dataset. Twenty unique KEGG pathways 
were represented among inferred metagenomes and showed striking similarity between 
sinus and lung samples (Figure S1, Appendix). This suggests that the functional capacity 
of lung and sinus bacterial communities is relatively similar, despite taxonomic differences. 
 To further summarize PICRUSt output, we utilized BugBase, a bioinformatics tool 
that infers community-wide phenotypes from predicted metagenomes (Ward et al., 2017). 
BugBase identified that gene functions associated with anaerobiosis were enriched in lung 
samples (P = 0.01), and could be attributed to three genera: Veillonella, Prevotella, and 
Porphyromonas (Figure 5A). Gram-negative ultrastructure and biofilm formation are two 
bacterial phenotypes often associated with airway pathogenicity, however, our analysis 
showed that these phenotypes did not differ significantly between sites. Gram-negative 
genera contributing to this phenotype were more varied in lung samples and included 
Veillonella, Prevotella, Neisseria, Stenotrophomonas, supporting the increased richness 
observed in these samples. Biofilm-forming bacteria were observed in both sinus and lung 
predicted metagenomes. This phenotype was influenced by the presence of Pseudomonas 
in both airway sites, but Burkholderia and Achromobacter both differentiated sinus from 
lung samples, while Neisseria and Stenotrophomonas were more highly represented in lung 
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samples. Altogether, these data point towards the lung environment being a more anaerobic 
niche, but that other phenotypes classically linked to bacterial pathogenicity, such as 




 It is poorly understood how complex bacterial communities promote the 
development of sinus disease. It is also not known how upper airway microbiota 
contributes to lower airway infections that are a primary cause of CF patient morbidity. 
The sinuses have been proposed as a reservoir in which individual pathogens adapt to the 
host prior to lung colonization, but it is unclear whether polymicrobial community 
composition of the CF lung can be a reasonable surrogate for upper airway microbiota and 
treatment of CF-CRS. We therefore took an ecological approach towards exploring 
bacterial diversity throughout the airways. 
 Our cohort showed striking variability in bacterial community membership 
between subjects. Despite this variability, we found that lung samples harbored an 
increased diversity (evenness) relative to sinuses which were dominated by either 
Staphylococcus or Pseudomonas. The abundances of these two canonical pathogens are 
commonly revealed by sinus culture (Mainz et al., 2009), though many other taxa identified 
in our study are not. For example, when compared to summarized culture data comparing 
the upper and lower CF airways (Fischer et al., 2014), the most striking difference between 
analyses was the identification of obligate anaerobes. These differences highlight the utility 
of molecular-based methods in detecting fastidious and anaerobic bacterial taxa. Given the 
emerging evidence of anaerobes being causative agents of pulmonary disease (Flynn et al., 
2016), increased use of culture-independent diagnostics to detect these bacteria throughout 
the airways is warranted. 
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 Our most intriguing data were that several sinus samples harbored canonical CF 
pathogens, yet these bacteria were absent in the paired lung samples. Conversely, the lungs 
of several subjects were colonized by a dominant pathogen that went undetected in the 
upper airways. This study outcome has significant clinical implications; respiratory 
cultures and sequence data from the two sites are not necessarily interchangeable for the 
determination of antibiotic therapy. These findings are consistent with those of Muhlebach 
(Muhlebach et al., 2006) who showed that bronchoalveolar lavage and oropharyngeal 
cultures are poor predictors (40–50% accuracy) of sinus bacteriology in children. Together, 
these observations may partially explain why patient response to therapy is poor, and 
suggest that the expanded use of non-invasive, sequence-based sinonasal sampling 
measures could be beneficial in steering patient therapies. 
 Often in microbiome surveys, bacterial membership may differ dramatically 
between samples, but functional capabilities remain conserved (Huttenhower et al., 2012). 
Here, we highlight this relationship in the airways. Contrasting differences in bacterial 
diversity and community composition between sinuses and lungs, we found that the 
predicted functional capacity in both niches was similar. In the context of bacterial 
contribution to CF disease, it is plausible that there are many similarities in the 
microenvironments of the upper and lower airways that may contribute, or even result from 
these conserved functions. 
 This exploratory study reveals many opportunities for future research. Notably, this 
work focuses on a small adult cohort with lung function lower than 70% predicted (mean). 
While the inter-individual variability reported is not unfounded, it highlights the need for 
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increased enrollment for assessing clinical and sequencing variables. Moreover, future 
work should extend to both pediatric and adult subjects across the spectrum of disease 
severity, as our conclusions may not be generalizable to all subjects. For example, it is 
possible that in patients where lung-adapted strains differ in prominence, the influence of 
bacterial trafficking from the upper airways on bacterial structure also varies. Likewise, 
longitudinal studies are warranted to investigate microbiota trafficking dynamics over time 
as patients age. Our work also does not account for airway microenvironments harboring 
distinct microbiomes. For example, a single maxillary sinus may not capture an infectious 
agent present in another sinus, whereas sputum may reflect multiple lower airway niches. 
Prior studies have shown that the middle meatus is a valid representation of the sinus cavity 
(Ramakrishnan et al., 2016), though multiple samples that define the biogeography of the 
upper airways will be informative for infection management. Finally, a common concern 
in sputum-based studies is the potential for salivary contamination. Though we cannot rule 
out the contribution of oral flora to our analyses, samples from lung explants and 
bronchoalveolar lavage have clearly demonstrated the presence of oral-associated 
anaerobes in the lung (Blainey et al., 2012; Hogan et al., 2016). Moreover, others suggest 
that contamination of sputum is limited during transit through the oral cavity (Blainey et 
al., 2012; Charlson et al., 2011). Moving forward, oropharyngeal swabs should be included 
in analyses to help define the site of sequence origin, particularly for diagnostic purposes. 
 Despite these limitations, our data shed important light on microbial community 
relationships throughout the CF airways. Though airway niche spaces differ in diversity, 
shared taxa between the sample pairs reflects the interconnectedness of the airway and does 
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not discount the sinuses as a source of lower airway colonization. However, the distinct 
bacterial community structures suggest sinus and lung microenvironments play a critical 
role in governing the prevalence and abundance of canonical CF pathogens. These data can 
be translated to the clinic by informing caregivers to utilize respiratory specimens 
originating from the site of infection. In the context of our findings, we advocate for the 
use of 16S rRNA gene sequences in the clinical setting to supplement culture data in the 
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Figure 2.1 Bacterial Load in Sinus and Lung Samples. 16S gene copies are greater in CF lung 
sputum compared to sinus samples, and correlate with patient age. Quantitative PCR was 
used to enumerate 16S rRNA gene copies ng of genomic DNA isolated from sinus and 
lung samples. A. Comparison of 16S rRNA gene copies in sinus and lung sample pairs by 
qPCR. (Paired Student's t-test P = 0.0637). B. Spearman correlations with 16S rRNA gene 
copies and patient clinical data. In sinus samples, 16S copies are positively and 





Figure 2.2 Bacterial community composition of the upper and lower airways. Stacked bar 
plots of relative abundances of genera in paired sinus and lung samples demonstrate 
dominance of Pseudomonas, Staphylococcus, and Streptococcus genera. Red patient 
numbers indicate samples where bacterial membership was significantly correlated within 
pairs. Data for these relationships is presented in Table S2. Pie charts show the average 




Figure 2.3 Alpha diversity of CF maxillary sinuses differs from CF lung sputum. A. Observed 
OTUs are modestly greater in lung samples compared to the sinuses. Lung samples display 
significantly greater evenness in OTU distribution relative to sinus samples (paired 
Student's t-test, P = 0.0127). B. Rank abundance curves reveal that both sinus and lung 
bacterial communities are dominated by a few organisms. 10 and 20 genera represent 99% 
of the sequences for sinus and lung samples, respectively. C. Spearman correlation heat 
map shows association of bacterial diversity (observed OTUs, Shannon), bacterial 16S 
gene abundance, and clinical factors. (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001).  
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Figure 2.4 Ordination of weighted Unifrac distances. Principal Coordinate Analysis shows 
clustering by sample type and dominant organism. A. Samples show more similarity by 
sample type rather than sampled individual (PERMANOVA, P = 0.019). Color and shape 
denote patient and sample type, respectively. Sinus and lung samples do not cluster by 
patient, but do show clustering by sample type. B. PCoA colored by relative abundance of 
dominant organisms (defined in text), shows sinus sample grouping is highly dependent on 




Figure 2.5 BugBase analysis of PICRUSt-predicted metagenomes. BugBase was used to 
summarize PICRUSt analysis results into categories based on bacterial phenotype. A. 
Anaerobic metabolism is significantly enriched in lung samples (Wilcoxon signed-rank 
test, P = 0.01). B. Biofilm formation does not differ significantly with sample type 
(Wilcoxon signed-rank test, P = 0.57). C. Gram-negative phenotype is driven by presence 
of Veillonella, Prevotella and Pseudomonas in lung samples (Wilcoxon signed-rank test, 
P = 0.47). (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001). 
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Chapter 3:  The microbiome of chronic rhinosinusitis in a cystic fibrosis patient 




 Chronic rhinosinusitis (CRS) affects nearly all individuals with cystic fibrosis (CF) 
and is thought to serve as a reservoir for pathogens that subsequently colonize the lung. To 
better understand the microbial ecology of CRS, we generated a 16S rRNA gene 
sequencing profile of sinus mucus from CF-CRS patients. We show that CF-CRS sinuses 
harbor bacterial diversity not entirely captured by clinical culture. Culture data consistently 
identified the dominant organism in most patients, though lower abundance bacteria were 
not always identified. We also demonstrate that bacterial communities dominated by 
Staphylococcus spp. were significantly more diverse compared to those dominated by 
Pseudomonas spp. Diversity was not significantly associated with clinical factors or patient 
age, however, younger subjects yielded a much wider range of bacterial diversity. These 
data mirror bacterial community dynamics in the lung and provide additional insight into 
the role of sinus microbiota in chronic airway disease progression.  
 42 
Introduction 
 Chronic rhinosinusitis (CRS) reaches a strikingly high prevalence among CF adults 
(>99%) (Chaaban et al., 2013). While there are several proposed causes of CF-associated 
CRS (CF-CRS), including abnormal sinus anatomy and aberrant immune responses 
(Benninger et al., 2003), bacterial infection remains widely implicated (Hoggard, 
Mackenzie, et al., 2017; Vickery et al., 2019). The “unified airway” model, whereby 
bacterial pathogens adapt to the upper airways before migration to the lungs has become a 
major impetus for studying CF-CRS microbiology (Godoy et al., 2011; Illing and 
Woodworth, 2014). 
 16S rRNA gene sequencing has significantly improved our understanding of CF 
microbial ecology. Cross-sectional and longitudinal studies of sputum have established that 
bacterial diversity decreases into adulthood, concomitant with lung function decline (Cox 
et al., 2010; Zhao et al., 2012). Fewer studies have investigated these dynamics in the upper 
airways, however, CF sinuses harbor significantly lower bacterial diversity compared to 
non-CF-CRS and non-CRS patients (Cope et al., 2017). Clinical culture has shown that 
Staphylococcus aureus and Pseudomonas aeruginosa are both prevalent and abundant in 
CF-CRS (L. Sobin et al., 2017), while their genotypes show within-individual concordance 
between upper and lower airways (Johansen et al., 2012). This relationship is particularly 
striking in lung transplant recipients (K. J. Choi et al., 2018; Ciofu et al., 2013; Mainz et 
al., 2009; Syed et al., 2016), supporting the notion that sinuses serve as a reservoir for CF 
lung pathogens. 
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 To better understand microbial community ecology in CF-CRS and its role in CF 
disease progression, we performed 16S rRNA gene sequencing on sinus mucus derived 
from patients undergoing endoscopic sinus surgery (ESS). We explored bacterial diversity 
with respect to dominance of canonical CF pathogens, patient demographics, and clinical 
parameters. We discuss these data in the context of interspecies interactions as 
determinants of CF pathogenesis.  
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Materials and Methods 
Study design 
The UMN Institutional Review Board (approval number #1403M49021) approved this 
study. Informed consent was obtained from all participants. Adult patients with CF (n=25) 
undergoing endoscopic sinus surgery for the treatment of CRS were enrolled at the 
University of Minnesota Department of Otolaryngology. Samples from 3 patients did not 
yield sequencing depth that exceeded 2000 reads and were excluded from analysis. 
Twenty-two patients were included in further analysis (Table 3.1). 
 
Sample collection DNA extraction 
 Sinus secretions were obtained from a single maxillary sinus (middle meatal region) 
under endoscopic visualization by suction into Argyle Mucus Traps (Cardinal Health, 
Dublin, OH) which were frozen at -80°C. Demographic data, recent clinical history, recent 
antibiotic and medication use (less than 3 months prior procedure date), and comorbidities 
such as presence of polyps, diagnosed asthma or allergies, GERD, were collected at time 
of surgery. 
 Genomic DNA was extracted from 300 µL of sinus mucus using DNeasy Powersoil 
kits (Qiagen, Carlsbad, CA) and submitted to the UMN Genomics Center (UMGC) for 16S 
rRNA gene library preparation1. The V4 region was amplified and sequenced using 
Illumina MiSeq TruSeq 2x300 paired-end technology. Reagent control samples were also 
sequenced. The samples were run as part of larger sample groups across four different 
sequencing runs. 
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16S rRNA gene sequencing and analysis 
 Sequence analyses, statistical analysis, and data visualizations were performed in 
R (v.4.0.0). Cutadapt (v.2.6) (Martin, 2011) was used to remove primer sequences, with 
size filtering set to 215bp (minimum) and 285bp (maximum). DADA2 (v.1.17.0) (Callahan 
et al., 2016) was used to trim sequences and filter for quality. DADA2 inferred a parametric 
error model used to identify and correct sequencing errors. Reads were de-replicated, 
paired ends merged, and chimeric reads removed using default options. Genus-level 
taxonomy was assigned using the Ribosomal Database Project (RDP) Bayesian classifier 
(Q. Wang et al., 2007) and SILVA-132 taxonomy training set (Quast et al., 2013). Species-
level taxonomy was assigned only if an amplicon sequence variant (ASV) unambiguously 
matched a sequence in SILVA-132 or eHOMD databases (Escapa et al., 2018). A 
phylogenetic tree was approximated by first performing a multiple-alignment using 
DECIPHER (v.2.14.0) (Wright, 2016). Phangorn (v.2.5.5) was used to construct a 
phylogenetic tree (Schliep, 2011). 
 Functions from the Phyloseq (v.1.33.0) (McMurdie and Holmes, 2013) and 
ampvis2 (v.2.6.0) (Andersen et al., 2018) R packages were used for abundance-related 
filtering of ASVs from the dataset, and diversity analyses. First, the resulting ASV table 
was rarified without replacement to 2000 sequences. Phyla with ambiguous taxonomic 
assignments, total feature prevalence less than 10, or mean feature prevalence of 1 were 
removed, as were ASVs with a mean relative abundance below 1x10-4. Ordination using 
double principal coordinate analysis (DPCoA) was carried out using the rarified ASV data 
transformed to proportions. Permutational multivariate analysis was carried out using 
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adonis in the vegan (v. 2.5-6) R package (Oksanen et al., 2013) and was used to test for 
differences in beta diversity centroids across patient data. The Shannon diversity metric 
was calculated for each sample individually using the rarified dataset. 
 
Data availability 





 Using 16S rRNA gene sequencing, we profiled bacterial community membership 
of CF-CRS mucus. Double principal coordinate analysis (DPCoA) was used to assess 
sample similarity with respect to taxonomic identity, phylogenetic relationships, and 
relative abundance (Figure 3.1A,B). Samples clustered into three groups defined by 
Firmicutes and Proteobacteria, with 52.3% of variation described on the first axis. 
Multivariate analysis showed no association between clinical parameters or comorbidities 
(polyps, GERD, asthma, allergies, prior sinus surgery, CFTR genotype) and the DPCoA 
(Figure 3.2A-F). 
 Hierarchical clustering and heatmapping were used to visualize relative abundances 
of bacterial genera (Figure 3.1C). Indeed, samples were differentiated by Firmicutes 
(Streptococcus, Staphylococcus) or Proteobacteria (Pseudomonas). Other Proteobacteria 
(Haemophilus, Achromobacter, and Burkholderia) were abundant, but at lower prevalence, 
and accounted for second axis variation. Several amplicon sequence variants (ASVs) were 
assigned specific epithets (i.e. 100% sequence identity without multiple database matches) 
(Table 3.2), allowing for comparisons to culture-based data (Figure 31D). With exceptions, 
the dominant genus identified by sequencing was also identified by culture, though the 
second most abundant genus was often not. Notably, Streptococcus was third most 
abundant and comprised primarily of ASVs assigned to S. intermedius. However, S. 
intermedius is not generally recovered clinically, underscoring the utility of molecular 
methods for bacterial identification.  
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 Many taxa identified by sequencing, particularly those with fastidious growth 
requirements (e.g. anaerobiosis) are not reported by clinical culture. This was particularly 
apparent in Staphylococcus-dominated samples, which tended to have greater bacterial 
diversity overall. Notwithstanding their lower abundance, we note that fastidious 
organisms (e.g. Prevotella, Veillonella) may also play a role in CRS, either through their 
own pathogenic potential or by affecting pathogen biology via interspecies interactions. 
 In most cases (21 of 22 samples), communities were structured by a taxon that was 
more than twice as abundant as the next highest-ranking taxon (Figure 3.3A). The top two 
dominant genera were Pseudomonas (9 samples, 41%) and Staphylococcus (7 samples, 
32%). Achromobacter, Burkholderia, Haemophilus, Streptococcus, and Veillonella were 
dominant in one sample each. Veillonella was noteworthy as it is not commonly considered 
pathogenic. We then compared alpha diversity (richness and evenness) between samples. 
Staphylococcus-dominated communities were significantly more diverse than those 
dominated by Pseudomonas (Wilcoxon, p=0.012) (Figure 3.3B). S. aureus is a known early 
colonizer of the CF lung, but as patients age, colonization with P. aeruginosa becomes 
more prevalent and coincides with a reduction in bacterial diversity (Coburn et al., 2015). 
Here, a significant relationship between age and Shannon diversity was not observed 
(Figure 3.3C), though diversity in samples from younger patients (16-25 years old) varied 
greatly compared to older age groups. Additionally, samples dominated by Staphylococcus 
in this group (50%) were greater than any other age. These data are consistent with the 
temporal acquisition of S. aureus and P. aeruginosa in the CF lung. 
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 Finally, colonization of the lung by either S. aureus or P. aeruginosa has been 
associated with pulmonary function decline (Ahlgren et al., 2015; Coburn et al., 2015). 
Given the “unified airway” hypothesis, we asked whether pathogen dominance in the 
sinuses fits this association (Figure 3.3D). While we found no statistically significant 
relationship, almost all patients with moderate to severe lung disease (FEV1%<70) yielded 
sinus mucus dominated by Pseudomonas. These data suggest that sinus microbiology may 




 CRS studies commonly use CF as an exclusionary criterion, limiting both culture-
based and molecular surveys of CF-CRS microbiota. However, the importance of sinus 
microbial ecology is underscored by the concordance of bacterial genotypes between upper 
and lower CF airways (Johansen et al., 2012). Data presented here support the notion that 
CF sinuses serve as a site for pathogen adaptation prior to chronic lung infection.  
 Bacterial diversity in CF sputum negatively correlates with age and pulmonary 
function decline (Cox et al., 2010; Klepac-Ceraj et al., 2010). Similarly, lung infections by 
the two most prevalent CF pathogens, S. aureus and P. aeruginosa, correlate with age; S. 
aureus is generally isolated from young CF patients and P. aeruginosa becomes the 
primary pathogen in adulthood (Salsgiver et al., 2016). Co-colonization also occurs and is 
associated with poor clinical outcomes (Limoli et al., 2016). Interestingly, many of these 
trends were observed in our CF-CRS cohort; (i) nearly all sinus mucus was dominated by 
either Pseudomonas or Staphylococcus (ii) 13 of 22 (59%) were co-colonized, (iii) 
community diversity and Staphylococcus-dominated samples were highest among younger 
subjects and declined with increasing age, and (iv) most sinus samples from patients 
exhibiting moderate to severe lung function were dominated by Pseudomonas. 
Collectively, these data suggest that CRS microbial dynamics may reflect, or even 
prognosticate, trajectories of CF lung infections. 
 By using amplicon sequence variants (ASVs), we improved upon the resolution by 
which microbiota associated with CF-CRS are surveyed (Table 3.2). We showed an 
increased diversity of bacterial species in Staphylococcus-dominated communities, 
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including those from Veillonella (V. dispar, V. parvula), Megasphaera (M. 
micronuciformis), Prevotella (P. melaninogenica, P. salivae), Corynebacterium (C. 
tuberculostearicum), several Streptococcus spp., and others. While contributions of these 
less prevalent and less abundant species to overall community stability and pathogenesis 
is currently unknown, their presence raises the question of whether interbacterial 
interactions are determinants of canonical CF pathogen dominance and/or virulence 
potential. Expanding in vitro investigations of interbacterial interactions will be critical to 
identify the contributions of community ecology to CF-CRS. 
 Sinusitis and its contributions to CF pathogenesis are poorly understood. Once 
thought to be sterile, sinuses are now known to harbor diverse polymicrobial communities 
that influence chronic bacterial colonization of the lung. Data presented here add to our 
emerging understanding of this important airway niche and its role in CF morbidity. 
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CFTR Mutation 2 
Homozygous 
dF508 






4 25 M dF508 R553X - + + - + - 0 66 
9 22 F dF508 dF508 + - + - + + > 4 76 
36 31 F dF508 1717-1G>A - + + - - + > 4 117 
38 22 M dF508 dF508 + + + - + + > 4 110 
51 33 M dF508 dF508 + - + - - + 2 69 
11 28 M dF508 dF508 + + + - - - 0 74 
18 22 F N1303K A1087P - + + - - + NA 85 
21 42 M dF508 dF508Polyp T  + + + - + + > 4 55 
47 16 M dF508 dF508 + + + - - + > 4 122 
61 31 M dF508 dF508 + + - - + + 2 NA 
85 26 M G551D 2789+5G>A - + - - + + NA 105 
87 19 F NA NA NA - - - - + > 4 NA 
94 26 F dF508 1717-1G>A - - - - - + 1 98 
102 32 F dF508 dF508 + + - + + + 1 31 
112 36 M dF508 L558S - - - + + - 0 26 
115 48 M dF508 W1282X - - - + - + 1 76 
130 22 F dF508 394delTT - - - - - + 2 101 
131 41 M 1717-1G-7A 3849+10kbc-T1 - + - - - + 1 72 
133 18 F dF508 dF508 + - - - - - 0 105 
158 36 F dF508 dF508 + - - - - + 1 61 
169 21 M dF508 dF508 + + - - - + > 4 94 








Average Relative  
Abundance (%) 
Burkholderia 1 99.70 
Burkholderia 1 99.70 
Streptococcus 11 67.43 
Streptococcus 7 1.48 
Streptococcus intermedius 2 51.20 
Streptococcus pneumoniae 1 14.30 
Streptococcus sanguinis 1 0.45 
Pseudomonas 22 46.75 
Pseudomonas 2 0.10 
Pseudomonas aeruginosa 20 46.65 
Haemophilus 5 41.28 
Haemophilus 3 38.35 
Haemophilus parainfluenzae 2 2.93 
Veillonella 19 36.22 
Veillonella 7 7.12 
Veillonella atypica 1 25.95 
Veillonella denticariosi 1 1.10 
Veillonella dispar 4 0.56 
Veillonella parvula 4 0.79 
Veillonella rogosae 2 0.70 
Achromobacter 5 34.08 
Achromobacter 1 9.00 
Achromobacter xylosoxidans 4 25.08 
Staphylococcus 19 30.23 
Staphylococcus 19 30.23 
Prevotella 21 9.26 
Prevotella 4 1.61 
Prevotella conceptionensis 1 0.15 
Prevotella histicola 2 2.23 
Prevotella melaninogenica 4 2.45 
Prevotella nanceiensis 1 0.15 
Prevotella nigrescens 2 0.10 
Prevotella oulorum 1 0.15 
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Prevotella pallens 2 1.20 
Prevotella salivae 4 1.23 
Stenotrophomonas 2 6.85 
Stenotrophomonas 1 6.70 
Stenotrophomonas maltophilia 1 0.15 
Klebsiella 3 6.43 
Klebsiella 3 6.43 
Capnocytophaga 5 4.20 
Capnocytophaga gingivalis 2 0.23 
Capnocytophaga leadbetteri 2 3.73 
Capnocytophaga sputigena 1 0.25 
Megasphaera 3 4.13 
Megasphaera micronuciformis 3 4.13 
Peptoniphilus 1 3.90 
Peptoniphilus 1 3.90 
Enterobacter 1 3.65 
Enterobacter 1 3.65 
Actinobacillus 2 3.38 
Actinobacillus 2 3.38 
Campylobacter 6 3.22 
Campylobacter 1 2.50 
Campylobacter concisus 5 0.72 
Neisseria 2 2.35 
Neisseria 2 2.35 
Corynebacterium 6 1.67 
Corynebacterium 1 0.15 
Corynebacterium tuberculostearicum 5 1.52 
Moraxella 3 1.50 
Moraxella 3 1.50 
Cutibacterium 7 0.49 










Figure 3.1 CF-CRS sinus communities differentiate by Proteobacteria or Firmicutes. (A-B) Double principal coordinates analysis (DPCoA) 
of CF-CRS sinus bacterial communities. In (A) each point represents a single sample/community (n=22) (B) Shows corresponding 
ASVs, colored by Phylum. (C) Hierarchical clustered heatmap of CF-CRS samples with the top 20 genera by mean relative abundance. 





Figure 3.2 DPCoA of bacterial community composition with clinical factors. Double principal 
coordinate analysis (DPCoA) of CF-CRS bacterial communities (n=22) colored by (A) 
polyps, (B) asthma, (C) gastroesophageal reflux disease (GERD), (D) allergies, (E) prior 
FESS, and (F) homozygous F508 genotype. Adonis (‘vegan’ R package) was used to test 






Figure 3.3. Shannon diversity and dominant Pseudomonas or Staphylococcus. (A) Number 
and proportion of samples with a dominant genus present (n = 22). (B) Shannon diversity 
compared between Pseudomonas or Staphylococcus dominance (Wilcoxon test, p = 
0.012). (C) Shannon diversity compared to CF patient age (Kruskal-Wallis, p  = 0.3). Points 
are colored by dominant genus. (D) Lung function measured by FEV1% compared between 
dominant genera (Wilcoxon test, p = 0.14). Dashed line denotes level below which lung 
function is considered to be moderate to severe.  
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Chapter 4:  Anaerobic mucin degrading bacterial communities differentiate the 






 Chronic rhinosinusitis (CRS) describes a group of inflammatory disorders 
characterized by chronic sinonasal inflammation for which the etiology is incompletely 
understood. Culture-based and genomic methods have provided support for the presence 
of similar bacterial taxa in the CRS and non-CRS sinuses, confounding the role of bacteria 
in pathogenesis. The presence of anaerobic bacterial taxa has been associated with CRS 
cases that are recalcitrant to treatment, suggesting they may play a role in pathogenesis 
either directly or through community-level interactions. 16S rRNA gene sequencing data 
presented in this chapter demonstrates the increased relative abundance of anaerobic 
bacterial genera belonging to Streptococcus, Prevotella, and Fusobacterium in CRS sinus 
mucus, in contrast with the higher relative abundance of Actinobacteria in non-CRS sinus 
mucus. From these data, we hypothesized that bacterial consortia associated with CRS 
would have an anaerobic mucin-degrading phenotype, and that anaerobic mucin 
degradation could augment CRS pathogen S. aureus growth in vitro. Functional predictions 
made from the amplicon sequence variants were compared to the carbohydrate active 
enzyme database (CAZy) and suggest increased genetic potential for mucin degradation in 
CRS-associated communities. Anaerobic enrichments of CRS sinus mucus in minimal 
medium with mucin (MMM) as the sole nutrient source yielded communities that degraded 
high-molecular weight mucins and were characterized by genera Streptococcus, 
Prevotella, and Fusobacterium. We demonstrated that in vitro aerobic growth of S. aureus 
on cell-free supernatants (CFS) derived from CRS-enrichment cultures is enhanced 
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compared to MMM alone. Finally, transcriptional profiles of S. aureus grown on CFS 
revealed that mucin degradation and fermentation products can alter metabolism- and 
virulence-associated gene expression. From these experiments we conclude that there is an 
anaerobic mucin-degrading phenotype associated with bacterial communities found in the 
CRS sinonasal cavity. Furthermore, cooperative mucin-degradation by these communities 
can affect S. aureus physiology and virulence potential in vitro. This research provides 
novel insight into the metabolic activities and interbacterial interactions of CRS 





 Chronic sinusitis (CRS) is a heterogeneous inflammatory disease of the upper 
airways that affects 2-13% of the US population (Bhattacharyya and Gilani, 2018). Despite 
its prevalence, the complex pathogenesis of CRS is poorly understood. The disease has 
been linked to anatomic variation, immune dysfunction, host genetics, impaired mucus 
clearance, and microbial dysbiosis2, but the importance of these factors and the order in 
which they occur remains controversial (Hoggard, Mackenzie, et al., 2017; Ooi et al., 
2008). General consensus is that bacterial infection is integral to CRS pathogenesis. Thus, 
antibiotic therapy remains standard-of-care (Hoggard, Mackenzie, et al., 2017). However, 
given the low efficacy of conventional treatment regimens and rising concerns about 
multidrug resistance (Essack and Pignatari, 2013; Kennedy and Borish, 2013; Manarey et 
al., 2004), there remains a critical need to understand the precise role(s) of upper airway 
microbiota in CRS. 
 S. aureus is recognized as a primary pathogen of CRS and is the most common 
bacterium isolated from both inpatient and outpatient cultures (Busaba et al., 2004; Feazel 
et al., 2012; Ramakrishnan et al., 2013). Paradoxically, S. aureus also resides, persistently 
or intermittently, in the nasal cavity of up to 50% of adults without complications (Bassis 
et al., 2014; Gorwitz et al., 2008; Wertheim et al., 2005). Individuals colonized by S. aureus 
tend to retain the same strain over time, and S. aureus infections tend to be caused by the 
carried strain (Bode et al., 2010; Pugliese and Favero, 2001; H. F. L. Wertheim et al., 2004). 
Interestingly, total bacterial load is not significantly different between CRS and non-CRS 
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subjects colonized by S. aureus (Abreu et al., 2012; Ramakrishnan et al., 2013). This 
observation suggests that extrinsic host and environmental variables, not bacterial 
overgrowth, are determinants of the commensal versus pathogenic lifestyle of S. aureus 
within the upper airways. 
 S. aureus pathogenesis can be attributed to its vast repertoire of virulence factors 
whose expression is dependent on complex regulatory networks, growth phase, and diverse 
environmental stimuli (Balasubramanian et al., 2017; Jenul and Horswill, 2018). 
Interactions with co-colonizing microbiota can also affect S. aureus pathogenicity, 
particularly in the sinonasal cavity, where S. aureus thrives as part of a complex microbial 
community. For example, it has been suggested that Cutibacterium spp. can inhibit S. 
aureus growth through propionic acid production, and decrease virulence via extracellular 
porphyrins (Y. Wang et al., 2014; Wollenberg et al., 2014). Similarly, Corynebacterium 
spp. restrict S. aureus pathogenesis through bactericidal activity (Hardy et al., 2019) or by 
suppressing the expression of virulence factors (Ramsey et al., 2016). Early culture-based 
studies found facultative and obligate anaerobic bacteria to be associated with CRS (I 
Brook et al., 1994; Erkan et al., 1994, 2009), significantly so in comparison to non-CRS 
subjects (Klossek et al., 1998). A longitudinal study also implicated colonization by 
facultative and obligately anaerobic bacteria as a significant risk factor in CRS 
development (I Brook et al., 1996). However, mechanistic contributions of anaerobes to 




 We recently demonstrated that commensal microbiota potentiate the growth and 
virulence of airway pathogens through the degradation of mucin glycoproteins (Flynn et 
al., 2020). Specifically, fermentation of O-linked oligosaccharides by oral-associated 
anaerobes generates amino acids and mixed-acid fermentation metabolites that P. 
aeruginosa can then use as nutrient sources. Building on our prior work and reports of 
hypoxia and increased mucin expression (MUC5B, MUC5AC) in CRS (Ding and Zheng, 
2007; Kim et al., 2004), here we tested the hypothesis that CRS microbiota are 
characterized by anaerobic mucin-degrading activity. Using 16S rRNA gene sequencing 
we found that, as expected, S. aureus abundance did not differ between CRS mucus and 
non-CRS controls. However, a significant decrease in the relative abundance of 
Actinobacteria (Corynebacterium, Cutibacterium) in CRS was observed that inversely 
correlated with an increase in Bacteroidetes (Prevotella) and Fusobacteria. We then 
hypothesized that an increase of these known mucin-degrading taxa would alter the 
nutritional landscape of the sinuses and drive a shift in S. aureus physiology from 
commensalism to pathogenesis. Indeed, we discovered that by degrading and fermenting 
mucins into bioavailable substrates, S. aureus growth was supported. Finally, RNAseq 
analysis demonstrated that mucin-degrading bacterial consortia differentially modulate 
gene expression in S. aureus, including several genes associated with central metabolism 
and virulence. This work reveals a mechanism whereby bacterial metabolic functions and 
interactions have critical implications for the onset, progression, and treatment of chronic 
sinus disease.  
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Materials and Methods 
FESS Sample Collection  
 69 participants with a positive diagnosis of CRS undergoing functional endoscopic 
sinus surgery (FESS) and 19 participants with no history of CRS, but undergoing unrelated 
sinonasal surgery, were recruited at the University of Minnesota Department of 
Otolaryngology. Exclusion criteria were diagnosis of cystic fibrosis, granulomatous 
polyangiitis, sarcoidosis, or Churg-Strauss syndrome. Informed consent was obtained from 
all subjects. Prior to surgery, each patient completed a sino-nasal outcomes test (SNOT-
22) (Kennedy et al., 2013). Sinus secretions were obtained from a single maxillary sinus 
(middle meatal region) under endoscopic visualization by suction into Argyle Mucus Traps 
(Cardinal Health, Dublin, OH) which were frozen at -80°C. Clinical data were also 
obtained for each subject (Table 4.1). The UMN Institutional Review Board approved these 
studies (#1403M49021).  
 
DNA extraction, 16S rRNA gene sequencing, and analysis  
 Genomic DNA was extracted from 300 µL of mucus using DNeasy Powersoil kits 
(Qiagen, Carlsbad, CA) and submitted to the UMN Genomics Center (UMGC) for 16S 
rRNA gene library preparation (Gohl et al., 2016). The V4 region was amplified and 
sequenced using Illumina MiSeq TruSeq 2x300 paired-end technology. Reagent control 
samples were also submitted and were below detection thresholds. 
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 Sequence analyses, statistical analysis, and data visualizations were performed in 
R. Cutadapt/2.6 (Martin, 2011) was used to remove primer sequences, with size filtering 
set to 215bp (minimum) and 285bp (maximum). DADA2/1.14 (Callahan et al., 2016) was 
used to trim sequences and filter for quality. DADA2 inferred a parametric error model 
used to identify and correct sequencing errors. Reads were de-replicated, paired ends 
merged, and chimeric reads removed using default options. Genus-level taxonomy was 
assigned using the RDP bayesian classifier (Q. Wang et al., 2007) and SILVA-132 
taxonomy training set (Quast et al., 2013). Species-level taxonomy was assigned only if an 
amplicon sequence variant (ASV) unambiguously matched a sequence in SILVA-132 or 
eHOMD databases (Escapa et al., 2018). A phylogenetic tree was approximated by first 
performing a multiple-alignment using DECIPHER/2.14.0 (Wright, 2016). Phangorn/2.5.5 
(Schliep, 2011) was used to construct a phylogenetic tree. Resulting data were filtered to 
include samples with greater than 2000 reads. Phyla with ambiguous taxonomic 
assignments, total feature prevalence less than 10, or mean feature prevalence of 1 were 
removed, as were ASVs with a mean relative abundance below 1x10-4. 
 PICRUSt2 (Douglas et al., 2020) was used to perform hidden-state prediction of 
metagenomic content, summarized into enzyme classes (ECs). Carbohydrate active ECs 
were identified through comparison to the Carbohydrate Active Enzyme Database (CAZy) 
(Lombard et al., 2014), downloaded from the dbCAN2 meta server (Zhang et al., 2018). 
EC count abundances were normalized to relative abundances of the top ten contributing 
ASVs in each subject group (CRS/non-CRS). 
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Bacterial strains and culture conditions. 
 Enrichments of mucin-degrading microbial communities were obtained through 
inoculation of a defined minimal mucin medium (MMM) (Flynn et al., 2016) with 100 uL 
of FESS-derived mucus. Cultures were incubated at 37°C under anaerobic conditions 
(5%H2, 5%CO2 90% N2) in a Coy anaerobic chamber (Coy Lab Products, Grass Lake, MI) 
without mixing for 48 hours, sub-cultured 1:100 into fresh MMM, and incubated for 
another 48 hours. Aliquots for 16S rRNA gene sequencing and 20% glycerol stocks were 
retrieved from each enrichment culture and stored at -80°C. Cell-free supernatants (CFS) 
were generated through inoculation of MMM from glycerol stocks and incubated for 48 
hours at 37°C under anaerobic conditions. Each culture was then sub-cultured 1:100 in 
MMM and incubated for 48 hours. Cells were removed by centrifugation at 7000 x g for 
10 min, followed by filtration through a 0.2 um polyethersulfone (PES) membrane filter. 
Filtrates were stored at -80°C until use. 
 S. aureus strain USA300 LAC (Diep et al., 2006) was maintained on tryptic soy agar 
(TSA). Prior to all growth experiments, overnight cultures were grown in tryptic soy broth shaking 
at 220 RPM at 37°C. Cells were washed three times with phosphate buffered saline (PBS) and 
diluted to an optical density (OD600) of 0.02 in MMM or CFS. Amendments to MMM included 
0.25% glucose (MMMG), 0.5% lactate (0.5%) (MMML), casamino acids (0.5%) (MMMC), or 
lactate (0.5%) and casamino acids (0.5%) (MMMLC). Respiratory conditions were induced in 
anaerobic cultures by addition of 3mM sodium nitrate. OD600 measurements were obtained using 
a Synergy H1 plate reader (BioTek, Winooski, VT) with continuous orbital shaking (282 cycles 
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per minute) at 37°C. Growth experiments were performed in triplicate using three biological 
replicates. 
 
FPLC/HPLC analysis of CFS 
 Fast protein liquid chromatography (FPLC) was used to evaluate the integrity of 
high molecular weight mucins. Using an Ӓkta Pure FPLC (GE Healthcare Bio-Sciences, 
Marlborough, MA) at 4C, 500 uL of MMM or CFS was injected and subject to an isocratic 
run at a flow rate of 0.4 mL/min for 1.5 CV with 50 mM phosphate buffer (pH 7.2) and 
150 mM NaCl on a 15mL column volume (CV) 10/200mm Tricorn column packed with 
Sepharose 2B-CL beads. Data were collected using Unicorn 7 software (GE Healthcare 
Bio-Sciences AB, Uppsala, SE) and analyzed using a custom R script. 
 High-performance liquid chromatography (HPLC) was used to measure concentrations of 
acetate, butyrate, propionate, lactate, succinate, and pyruvate using pure standards ranging from 
0.1 mM to 10 mM. To remove high molecular weight glycoproteins, CFS were filtered using 
regenerated cellulose protein concentrators (3000 MWCO; Amicon, MilliporeSigma). Eluent was 
analyzed using a Dionex UltiMate 3000 UHPLC (Thermo Fisher) system equipped with an 
Acclaim Organic Acid Column (5um, 120A, 4.0x250mm). A 32-minute isocratic instrument 
method was used for analysis consisting of an 8-minute equilibration period followed by a 24-
minute sample run at 1.0ml/min at 30°C. Sodium sulfate (100mM, pH 2.6) was the mobile phase. 
All samples were analyzed at a wavelength of 210nm. Chromeleon 7 software (Dionex, Sunnyvale, 
CA, USA) was used to visualize and process data, and Cobra Wizard was used to identify and 
automatically gate chromatogram peaks of interest. 
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RNA Isolation, RNA-Seq, and data analysis 
Total RNA was extracted from 5 mL cultures grown to early stationary phase in CFS, or 
MMMG following a previously described method (Carroll et al., 2014) with modifications. 
Briefly, cells were pelleted by centrifugation for 5 minutes at 7000 x g and snap frozen in 
liquid nitrogen before storage at -80°C overnight. RNA was extracted from cell pellets 
using an RNeasy Mini kit (Qiagen). DNaseI treatment was carried out as part of the RNA 
Clean and Concentrator kit (Zymo, Irvine CA). RNA quality (RIN ≥ 9.8) and quantity were 
assessed using an Agilent Bioanalyzer. Paired-end 75bp libraries were prepared by UMGC 
using Illumina TruSeq Stranded RNA workflow with bacterial ribosomal reduction using 
Ribo-Zero (Illumina, San Diego, CA). Libraries were sequenced using the Illumina 
NextSeq platform. 
 Raw fastq files were checked for quality and adapter sequences using FastQC. 
Sequences were then aligned to the USA300_FPR3757 genome (NCBI RefSeq 
NC_007793.1) (Diep et al., 2006) using the Subread aligner, implemented using RSubread 
(Liao et al., 2013, 2019). Gene counting for each sample was performed using 
‘featureCounts’, also using RSubread. Sample ordination was carried out on regularized-
log transformed counts using ‘rlog’ and ‘pcomp’ functions within DESeq2/3.9 (Love et al., 
2014). The ‘deseq’ function was used to estimate size factors, carry out variance-stabilizing 
transformation and statistical testing via the Wald Test. Genes with a log2 fold-change 
greater than 1 (set using the lfcThreshold parameter) with two-tailed Benjamini-Hochberg 










CRS is associated with an anaerobic mucin-degrading bacterial phenotype 
 To first test our hypothesis that CRS sinuses harbor an increased prevalence of 
anaerobic microbiota, we obtained sinus mucus from CRS (n=61) and non-CRS (n=19) 
subjects. Community composition was described using taxonomy derived from amplicon 
sequence variants (ASVs) generated from 16S rRNA gene sequence analysis. 
Demographic and clinical data associated with each subject were also obtained (Table 4.1). 
A comparison of bacterial communities using double principal coordinate analysis 
(DPCoA) revealed considerable within-group variation among CRS microbiota (Figure 
4.1A). With exceptions, non-CRS samples clustered more closely compared to CRS 
samples. The split plot demonstrated 53.5% variation represented along the first axis which 
suggests that CRS samples deviate from non-CRS based on the presence/absence of 
Actinobacteria, Bacteroidetes, and Fusobacteria. Indeed, a greater relative abundance of 
Actinobacteria was significantly associated with non-CRS samples (Wilcoxon, P < 0.001) 
(Figure 4.1B). A greater relative abundance of Actinobacteria was also significantly 
associated with samples from patients with no prior history of FESS (Wilcoxon, P = 0.015) 
(Figure 4.1C), suggesting an association with earlier stages of disease. Actinobacteria also 
exhibited an inverse relationship with the relative abundance of both Bacteroidetes and 
Fusobacteria (Wilcoxon, P < 0.001, Figure 4.1D). Second axis variance in the DPCoA 
(11%, Figure 4.1A) was primarily driven by Proteobacteria. Relative abundances of phyla 
across all samples are shown in Figure 4.2. These analyses demonstrate that while CRS 
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and non-CRS samples share many of the same bacterial taxa, differences between groups 
occur at the phylum level. 
 Where identification of obligate anaerobes in CRS has been previously hindered by 
cultivability, sampling, or database representation, we leveraged the increased resolution 
of ASVs over conventional use of molecular operational taxonomic units (OTUs) to 
provide a detailed characterization of bacterial diversity in the sinus cavity (Table 2). At 
the genus level (Figure 4.1E), relative abundances of Staphylococcus spp. did not 
appreciably differ between CRS (11%) and non-CRS (15%), as expected. These data 
support previous culture-based and culture-independent studies demonstrating similar 
prevalence and abundance of S. aureus between patient groups (Abreu et al., 2012; 
Ramakrishnan et al., 2013). In agreement with the DPCoA (Figure 4.1A), non-CRS 
samples were distinguished by Actinobacteria – Corynebacterium (14% vs 6%), 
Cutibacterium (3.6% vs 1.1%), and Actinomyces (1.1% vs 0.2%) – consistent with their 
roles as commensal inhabitants of the upper airways while attenuating S. aureus 
pathogenicity (Hardy et al., 2019; Ramsey et al., 2016; Y. Wang et al., 2014; Wollenberg 
et al., 2014). ASVs belonging to Pseudomonas and Staphylococcus were second and third 
most abundant in CRS, respectively, consistent with their role as airway pathogens. Most 
notable, however, was that Streptococcus was highly abundant in CRS at an average 
relative abundance of 17.2% compared to 6.8% in non-CRS subjects. Prevotella and 
Fusobacterium, both obligate anaerobes, were also more abundant in CRS. Together, these 
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data suggest that the CRS sinus bacterial communities exhibit a loss of commensal taxa, 
and favors (and/or is driven by) growth of facultative and obligate anaerobes. 
 Given the association of Streptococcus, Prevotella, and Fusobacterium with oral- 
and gut-associated bacterial communities known for metabolizing host-derived mucin 
glycoproteins (Argüeso et al., 1998; Beighton and Whiley, 1990; Bradshaw et al., 1994; 
Byers et al., 2000; Homer et al., 1996; Kiyohara et al., 2010; Mondal et al., 2014; Rho et 
al., 2005; Sanders et al., 2007; Tailford et al., 2015; Terra et al., 2010; Wickström et al., 
2009; D. P. Wright et al., 2000), we then hypothesized that CRS microbiota would exhibit 
the functional capacity to degrade mucins, which are increased in expression in CRS (Ding 
and Zheng, 2007; Kim et al., 2004). To test this hypothesis, we used PICRUSt2 (Douglas 
et al., 2020) to predict metagenomic content based on 16S rRNA sequencing data, which 
was then summarized into enzyme categories (ECs) and compared to the Carbohydrate 
Active Enzyme (CAZy) database (Lombard et al., 2014). Selection of the top CAZy EC 
classes by relative functional abundance revealed that glycoside hydrolases and 
polysaccharide lyases were more prevalent in CRS predicted metagenomes (Figure 4.3A), 
including many with previously defined roles in mucin degradation (β-glucuronidase, β-
galactosidase, hyaluronate lyase, exo-α-sialidase, and chitinase). By contrast, 
metagenomes predicted from non-CRS samples were characterized by the presence of ECs 
with glycotransferase (GT) and carbohydrate esterase (CE) functions (Figure 4.3B). These 
in silico analyses are predictive of CRS microbiota having increased capacity for cleavage 
of glycosidic bonds and degradation of mucin oligosaccharides. 
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 To validate our metagenome predictions, and to demonstrate that CRS microbiota 
retain their mucin degradation capacity in vivo, we used an anaerobic enrichment scheme 
(Flynn et al., 2016) in which sinus mucus was serially passaged in a defined growth 
medium containing 15g L-1 purified MUC5AC as the carbon source (minimal mucin 
medium, MMM). After two passages of 48h, bacterial composition pre- and post-
enrichment was profiled. Similar to our initial sequencing data (Figure 4.1), CRS subjects 
harbored diverse bacterial communities, often dominated by a single recognized pathogen 
(Figure 4.4A). Post-enrichment mean relative abundances of Prevotella (19.4%), 
Veillonella (19.7%), Fusobacterium (13.3%) and Streptococcus (15.3%) all increased 
across samples (Figure 4.4B). Enrichment cultures were similar between patients, even 
when original community membership differed (Figure 4.4C), suggesting a core mucin-
degrading consortium. FPLC was also used to assess integrity of high-molecular weight 
mucins included in the enrichment medium. As predicted, chromatograms (Figure 4.4D) 
show that the peak area derived from each bacterial community was markedly decreased, 
reflecting reduced mucin integrity as a result of enrichment. Together, these data support 
our hypothesis that anaerobic microbiota alter the CRS microenvironment via degradation 
of mucin glycoproteins. 
 
S. aureus growth on mucin is inefficient and respiration dependent. 
 When Staphylococcus ASVs were present in the original sample (subjects B-F, H), 
they were notably absent from the enrichment (Figure 4.4A). This suggests that 
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Staphylococcus spp. are either (i) inhibited by enrichment communities, (ii) unable to 
efficiently use mucins or degradation byproducts as nutrients, or (iii) unable to do so under 
oxygen limitation, despite fermentative capacity. To test these possibilities, S. aureus strain 
USA300 LAC was first grown aerobically in MMM. Growth was limited on MMM alone, 
suggesting that metabolic requirements are not met by intact high-molecular weight 
mucins. However, growth rate and yield were significantly increased when supplemented 
with casamino acids, lactate, and glucose, which mimic metabolites generated via mucin 
degradation and fermentation (Figure 4.5A). Growth on these supplements was restricted 
under anaerobic (fermentative) conditions but was partially restored with the addition of 
3mM sodium nitrate as an electron acceptor (Figure 4.5B). From these results it can be 
concluded that S. aureus does not efficiently use mucins as a nutrient source. As expected, 
the in vitro conditions support growth when additional nutrients are supplied, particularly 
under respiratory conditions.  
 
Secondary metabolites from mucin degradation support S. aureus growth. 
 To test whether degradation and fermentation by other bacteria could provide 
nutrients to S. aureus, and to ensure that S. aureus was not inhibited by co-colonizing 
microbiota, LAC was cultured on cell-free supernatants (CFS) derived from enrichment 
samples (A-H in Figure 4.4) under aerobic and anaerobic (respiratory and non-respiratory) 
conditions. Under aerobic conditions, LAC exhibited equal or improved growth in all CFS, 
despite having less total carbon in the growth medium (i.e. it was removed by anaerobes 
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during enrichment) (Figure 4.6A). Interestingly, communities A, E, and G which generated 
CFS supporting low S. aureus growth yields were enriched from samples in which 
Staphylococcus ASVs were absent or at very low abundance (see Figure 4.4A). 
 Anaerobic growth yields after 24h showed a similar pattern, signifying the presence 
of fermentable metabolites (e.g. glucose, galactose) as a result of mucin degradation 
(Figure 4.6B). Establishment of respiratory conditions with the addition of sodium nitrate 
(3mM) resulted in increased growth yields in all conditions. We conclude that aerobic and 
anaerobic growth of S. aureus can be supported by metabolites liberated or produced by 
CRS-derived mucin-degrading bacteria. 
 Byproducts of fermentation by mucin degrading communities constitute one source 
of metabolites that can alter S. aureus physiology. We used high performance liquid 
chromatography (HPLC) to measure fermentation byproducts acetate, propionate, 
butyrate, and lactate in the CFS (n = 1 replicate for each). We found these metabolites to 
be present in the millimolar range, and highly variable across supernatants. CFS-A with 
very low levels of SCFA, Succinate/Pyruvate, and CFS-E, with high levels of Acetate and 
Propionate, were also associated with the lowest growth rate and yield under aerobic 
conditions (Figure 4.6A). The two CFS-F and -H resulted in the greatest growth rates and 
yields, and also had higher levels of lactate, however, high lactate could not explain growth 
patterns seen in the other supernatants. There are likely many more other metabolites 
resulting from mucin-degradation not measured here that influence S. aureus growth in our 
in vitro conditions.  
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Mucin degradation supernatants influence S. aureus transcription 
 Increased S. aureus growth on CFS also raised the question of how metabolism, 
virulence, or other cell processes were modified at the transcriptional level. To gain insight 
into pathways that were differentially expressed in response to anaerobic mucin 
degradation, we used RNAseq to profile S. aureus gene expression during growth on cell-
free supernatants (CFS) relative to growth on MMM supplemented with glucose 
(MMMG), a preferred carbon source of S. aureus during infection (Vitko et al., 2016). CFS 
samples D, F, and H were selected for their consistent ability to support S. aureus growth 
under both aerobic and anaerobic conditions. 
 Differential gene expression in all three supernatants relative to MMMG is shown 
in Figure 4.7A. Across samples, 93 genes (79 upregulated, 14 downregulated) were 
differentially expressed (2-fold or greater, P < 0.05). Common to all supernatants was 
increased expression of genes in the nan locus involved in transport and catabolism of sialic 
acid (N-acetylneuraminic acid [Neu5Ac]) (Olson et al., 2013) (Figure 4.7 A, B). PTS-
dependent glucose and ManNAc transporter glcC (Vitko et al., 2016), was also 
differentially expressed. 
 Interestingly, there was increased expression of NAD-dependent formate 
dehydrogenase (fdh) and formyltetrahydrofolate synthetase (fhs), implying formate 
catabolism. However, these genes were not accompanied by increases in pyruvate formate 
lyase (pflA, pflB) expression, whose gene products supply formate to FDH and pyruvate 
for substrate-level phosphorylation (Leibig et al., 2010). The gene involved in the 
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conversion of acetate to acetyl-CoA (acsA) was also significantly increased (Figure 4.7C), 
but not the reverse process (pta, ackA). Altogether, these data suggest that mixed-acid 
fermentation metabolites such as formate and acetate are provided exogenously to S. 
aureus by CRS anaerobes. 
 An increase in expression of genes associated with glutamate import (gltS) and 
synthesis via catabolism of arginine (rocF, rocD, rocA) and proline (putA, rocA) was 
observed in the supernatant conditions (Figure 4.7A,C) (Halsey et al., 2017). Increased 
expression of gudB signifies glutamate conversion to 2-oxoglutarate for entry into the TCA 
cycle. Additionally, expression of genes associated with the left side of the TCA cycle and 
gluconeogenesis (sucA, sucC, sdhA, fumC, mqo1, pckA) were all significantly increased, 
indicating that amino acids may be fueling gluconeogenesis under the conditions tested. 
Other functional categories of genes consistently expressed across supernatants include 
peptidoglycan recycling (murQ) (Borisova et al., 2016), fatty acid metabolism (fadA, fadB, 
fadD, fadE, fadX) (Kenny et al., 2009), biotin biosynthesis (bioA, bioB, bioD, bioF, bioW, 
bioY) (Satiaputra et al., 2018), and virulence (spa and a gene encoding a putative 
immunoglobulin-blocking virulence protein, RS09510) (Balasubramanian et al., 2017). 
The differential transcription of these genes indicates that S. aureus metabolism is 
significantly altered in comparison to growth on glucose. 
 Several transcripts were differentially expressed between supernatants conditions. 
Hierarchical clustering revealed that the S. aureus transcriptome from CFS-H was distinct 
from CFS-D and CFS-F (Figure 4.7D). Transcripts associated with amino acid transport 
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and biosynthesis were more abundant in CFS-D/F. Of note was expression of the ilv-leu 
operon involved in branched-chain amino acid (BCAA) synthesis, accompanied by 
increased expression of genes encoding ɑ-acetolactate decarboxylase (budA) and ɑ-
acetolactate synthase (budB) (Kaiser and Heinrichs, 2018). Genes required for galactose 
import (lacCDEF) (Rosey et al., 1991) were also upregulated in CFS-D/F, suggestive of 
its availability in these supernatants. Genes involved in cysteine-sulfur-methionine 
homeostasis (ssuABC, metICFH-mdf operons) (Schoenfelder et al., 2013) and peptide 
transport (opp3DAF) (Lehman et al., 2019) were also seen at higher levels in CFS-D/F.  
 Virulence-related gene transcription also differentiated supernatant growth 
conditions. Notably, transcription of the agr operon and RNAIII (hld) were higher in CFS-
H. Protease transcripts staphopain B (sspB), aureolysin (aur), and immunodominant 
antigen B (isaB) were also more abundant in this condition. Supernatants CFS-D/F yielded 
transcriptomes that exhibited more of a biofilm-like phenotype, with increased prevalence 
of transcripts for holin protein (cidA) and exopolysaccharide (icaABC) (Cramton et al., 
1999; Rice et al., 2007). Taken together, these data demonstrate that, in addition to 
supporting S. aureus growth, expression of genes associated with metabolism, virulence, 
and other cellular processes is highly dependent on the specific composition of their co-





 S. aureus is consistently associated with the development of CRS, and the 
inefficacy of clinical therapies (Bhattacharyya and Kepnes, 1999; Ramakrishnan et al., 
2015). However, S. aureus is also present in the nasal passages of ~50% of healthy 
individuals (Bassis et al., 2014; Gorwitz et al., 2008; H. F. Wertheim et al., 2005), 
suggesting that the sinus microenvironment and bacterial activities within, may tip the 
balance between commensalism and pathogenesis of S. aureus in vivo. Here we 
demonstrate differences in CRS and non-CRS bacterial communities and implicate mucin 
as a nutrient source supporting anaerobic bacterial diversity in the sinuses. Moreover, we 
show that the degradation of mucins by CRS-derived communities impacts S. aureus 
growth and alters its transcriptional profile. 
 Research spanning several decades has described the microbiology of CRS, both 
by culture and molecular methods (Hoggard, Mackenzie, et al., 2017). There is general 
agreement in the prevalence of potential pathogenic bacteria implicated in disease, 
including S. aureus. However, surveying bacterial diversity in this niche is subject to bias 
in the observation of low abundance or fastidious organisms based on sampling methods, 
cultivability, and representation in databases for taxonomic assignment (Hoggard, 
Mackenzie, et al., 2017). Observation of anaerobes in CRS has therefore varied across 
studies (Itzhak Brook, 2011). Here, we leverage the use of ASVs for taxonomic 
assignment, resulting in high-resolution observations that both confirm species-level 
identification of anaerobes in culture-based studies (e.g. P. melaninogenica, F. nucleatum), 
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and contribute previously unreported bacterial species (e.g. F. periodonticum, Dialister 
invisus, Porphyromonas pasteri) (Table 2). Although this resolution is useful for 
generating hypotheses about potential interbacterial interactions, differences in bacterial 
consortia in CRS and non-CRS can also be seen at the phylum level. Actinobacteria relative 
abundance differentiates CRS subjects from non-CRS subjects, and within CRS subjects, 
is negatively correlated with the number of therapeutic surgical interventions (FESS). 
Interestingly, Corynebacterium (Actinobacteria) presence in the sinuses prior to FESS has 
been linked with better patient outcomes (Ramakrishnan et al., 2015), suggesting it is a 
member in a less inflammatory community. Furthermore, the relative abundance of 
Actinobacteria have an inverse relationship with both Bacteroidetes and Fusobacteria, 
suggesting that the presence of anaerobes may represent a distinct dysbiotic stage in CRS 
disease progression. 
 Hypersecretion of mucus is a hallmark of CRS disease (Ding and Zheng, 2007; 
Kim et al., 2004). Due to their complex structure, mucins, the main component of mucus, 
paradoxically provide both mucosal barrier protection and a rich source of nutrients for 
organisms that can degrade them (Wagner et al., 2018). In better characterized ecosystems 
such as the gut and oral cavity, mucins act as important mediators of microbial community 
assembly, requiring a diversity of glycolytic and proteolytic enzymatic functions for 
degradation (Wagner et al., 2018). Metagenomic prediction showing increased 
carbohydrate active enzyme abundances from CRS associated bacterial communities led 
us to hypothesize that mucins support anaerobic bacterial taxa in this niche. We found 
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mucins support the major anaerobic taxa observed in our original analysis, recovering 
communities dominated by Streptococcus, Veillonella, Prevotella, and Fusobacteria. The 
similarity across enrichment communities despite dissimilar original samples was striking. 
Interestingly, diverse metabolic phenotypes are represented within and between the top 
genera. Several species of Streptococcus and Prevotella have been noted for their 
saccharolytic capabilities necessary to break down mucin glycans (Bradshaw et al., 1994; 
Derrien and Passel, 2010; Wickström et al., 2009; D. P. Wright et al., 2000). By contrast, 
characterization of F.  nucleatum indicates it is only minimally saccharolytic, and instead 
relies on amino acid catabolism and peptide assimilation (Bradshaw et al., 1994; Loesche 
and Gibbons, 1968). Carbohydrate fermentation has not been described for Veillonella spp. 
which instead rely on fermentation byproducts such as lactate for growth (Ng and 
Hamilton, 1971). These results indicate that under anaerobic conditions, mucin degradation 
alone can support diverse bacterial metabolisms within a community. 
 A critical component of S. aureus’ capacity for colonization and virulence potential 
is its ability to adopt metabolic states given a range of nutrient sources and respiratory 
conditions (Carvalho et al., 2017; Halsey et al., 2017; Krismer et al., 2014; Spahich et al., 
2016), However, S. aureus use of mucins as a nutrient source has not been described, and 
our results demonstrate that intact, high molecular weight mucins do not support robust 
growth. Lactate, amino acids, and glycolytic substrates have all been indicated as important 
metabolites in models of S. aureus survival and pathogenicity (Spahich et al., 2016; Vitko 
et al., 2016), and their addition to MMM demonstrates that these metabolites support 
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growth under our experimental conditions. Proposed sources of these metabolites are host 
and S. aureus activities such as collagen degradation and carbohydrate fermentation 
(Halsey et al., 2017; Lehman et al., 2019). We hypothesized that co-colonizing bacteria in 
CRS can also provide these and other metabolites through mucin degradation and cross-
feed S. aureus. Counter to this prediction was the observation that the genus 
Staphylococcus was not recovered in any of our enrichment cultures, suggesting that 
antagonistic bacterial interactions, competition, or lack of oxygen or other nutrients was 
inhibiting Staphylococcal survival. However, when we used cell-free supernatants from 
CRS mucin-degrading communities, we showed that S. aureus grew to higher densities 
compared to mucin alone. Our results suggest that mucin degradation can supply nutrients 
to support S. aureus growth. Interbacterial interactions governing S. aureus co-existence 
with mucin-degrading communities, and the metabolic parameters that shape these 
relationships, are the subject of ongoing investigation.  
 The mechanisms whereby the microenvironment influences S. aureus ability to 
colonize mucosal surfaces, subvert the immune system, and initiate infection continue to 
be an active area of research. Respiratory microbiota have been shown to impact the 
microenvironment at the respiratory mucosa in non-trivial ways. For example, cleavage of 
sialic acids from host proteins is a well-documented characteristic of various members of 
the Streptococci seen in our study (Blanchette et al., 2016; Bradshaw et al., 1994). Our 
transcriptome analysis of S. aureus growth on three different supernatants from CRS-
derived mucin-degrading communities revealed upregulation of sialic acid transport and 
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catabolism genes from the nan locus, indicating a response to this carbon and nitrogen 
source. Current models of S. aureus metabolic adaptation under changing respiration and 
nutrient levels support a strong link between the metabolite pool, metabolic state, and 
virulence (Jenul and Horswill, 2018). Expression profiles revealed upregulation of many 
of the same pathways deemed important for S. aureus survival and virulence potential in 
these models, such as glutamate synthesis via arginine and proline (Halsey et al., 2017). 
Separately, the supernatants impacted virulence-related gene transcription in different 
ways. Genes of the agr locus, a master regulatory system controlling the expression of 
virulence factors including extracellular proteases (Jenul and Horswill, 2018), were 
upregulated only when S. aureus was grown in CFS-H. The transcriptional profiles of S. 
aureus grown in CFS-D/F exhibited gene expression associated with nitrosative stress 
tolerance, clumping, adhesion, and biofilm formation (Carvalho et al., 2017; Cramton et 
al., 1999; Rice et al., 2007). S. aureus exacerbation of CRS disease is complex, likely 
involving both inflammation-inducing virulence factor expression, and aggregation and 
biofilm formation known to reduce efficacy of antibiotic therapies (Archer et al., 2011). 
Altogether, our data show that mucin-degradation contributes to the microenvironment in 
significant ways, altering S. aureus growth and transcription. 
 The scope of our results is limited in that our observations only include bacteria. 
We acknowledge that fungi may be present in our samples as well, and mucin-fungal 
interactions have been reported previously. Additionally, we did not look further into the 
impact of community-derived proteins and small molecules in the supernatants that may 
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directly impact S. aureus growth and gene expression phenotypes, though there is 
precedence for these interactions. For example, Corynebacterium spp. quench S. aureus 
quorum sensing via small molecule interference (Ramsey et al., 2016). Finally, our 
observations of S. aureus growth and transcription were all conducted in monoculture, 
which excludes spatial and contact-dependent polymicrobial interactions, such as the 
recently demonstrated aggregate formation with Fusobacterium nucleatum (Lima et al., 
2019). Observations of increased virulence through protease expression, or biofilm 
formation will need to be tested in vivo to better understand the contribution of these 
interactions to the development and persistence of CRS. 
 Overall, our results suggest that a reduction in the relative abundance of 
Actinobacteria, including Corynebacterium, and increase in Bacteroides and Fusobacteria 
may represent a dysbiotic state in CRS. Members of Bacteroidetes, Fusobacteria and 
anaerobic Firmicutes are common members of mucin degrading communities, which can 
be isolated from CRS sinus mucus, and whose collective metabolic activities can support 
S. aureus growth and alter gene transcription. Our findings provide a basis for further 
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Table 4.1 Demographic and clinical data for FESS patients 
CRS Diagnosis CRS (n = 61) Non-CRS (n = 19) 
Age (mean ± S.D.) 49.5 ±13.8 43.1 ±14.4 
SNOT22 (mean ± S.D.) 1.9 ± 1.0 0.93 ± 0.8 
Sex (% Female) 52.5 42.1 
Polyps (%) 42.6 0 
GERD (%) 23.0 15.8 
Asthma (%) 50.8 5.3 





Table 4.2 Prevalence and average relative abundance of anaerobe features in CRS and non-



















Actinomyces           
Actinomyces 9 4 0.03 0.59   
Actinomyces graevenitzii 7 3 0.04 0.03 SILVA/HOMD 
Actinomyces odontolyticus 17 9 0.16 0.59 SILVA 
Total 33 16 0.23 1.22   
Akkermansia           
Akkermansia muciniphila 2 0 0.13 0.00 SILVA 
Total 2 0 0.13 0.00   
Anaerococcus           
Anaerococcus 7 6 0.57 0.22   
Anaerococcus nagyae 2 1 0.01 0.01 SILVA 
Anaerococcus octavius 6 8 0.19 0.37 SILVA/HOMD 
Anaerococcus provenciensis 1 3 0.00 0.27 SILVA 
Total 16 18 0.77 0.87   
Atopobium           
Atopobium parvulum 6 2 0.03 0.02 SILVA/HOMD 
Atopobium rimae 1 1 0.02 0.03 SILVA/HOMD 
Total 7 3 0.05 0.05   
Bacteroides           
Bacteroides 3 1 1.25 0.17   
Bacteroides acidifaciens 2 1 0.20 0.19 SILVA 
Total 5 2 1.46 0.36   
Campylobacter           
Campylobacter 6 4 0.07 0.36   
Campylobacter concisus 15 3 0.15 0.48 SILVA 
Campylobacter gracilis 5 0 0.28 0.00 SILVA/HOMD 
Campylobacter ureolyticus 1 2 0.00 0.07 SILVA/HOMD 
Total 27 9 0.50 0.91   
Capnocytophaga           
Capnocytophaga gingivalis 2 1 0.01 0.01 SILVA/HOMD 
Capnocytophaga leadbetteri 7 2 0.06 0.06 SILVA/HOMD 
Capnocytophaga ochracea 1 0 0.03 0.00 SILVA 
Total 10 3 0.09 0.07   
Cutibacterium           
Cutibacterium acnes 36 13 0.96 3.43 SILVA/HOMD 
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Cutibacterium granulosum 9 8 0.13 0.20 HOMD 
Total 45 21 1.08 3.62 SILVA/HOMD 
Dialister         SILVA 
Dialister invisus 7 2 0.05 0.07   
Dialister micraerophilus 0 1 0.00 0.09   
Dialister pneumosintes 8 3 0.33 0.06   
Dialister propionicifaciens 2 3 0.04 0.06 SILVA/HOMD 
Total 17 9 0.42 0.28   
Eikenella           
Eikenella 1 0 0.02 0.00 SILVA/HOMD 
Eikenella corrodens 4 0 0.05 0.00   
Total 5 0 0.07 0.00   
Finegoldia           
Finegoldia magna 11 9 1.16 0.50 SILVA/HOMD 
Total 11 9 1.16 0.50 SILVA/HOMD 
Fusobacterium         SILVA/HOMD 
Fusobacterium 16 2 1.53 0.08   
Fusobacterium necrophorum 1 0 0.02 0.00   
Fusobacterium nucleatum 18 5 3.39 2.94   
Fusobacterium periodonticum 14 4 0.45 0.43   
Total 49 11 5.39 3.46   
Gemella         HOMD 
Gemella 14 8 0.15 0.24 SILVA/HOMD 
Total 14 8 0.15 0.24   
Granulicatella           
Granulicatella adiacens 14 8 0.12 1.72   
Granulicatella elegans 6 2 0.04 0.03   
Total 20 10 0.16 1.74   
Oribacterium         SILVA/HOMD 
Oribacterium 2 0 0.02 0.00   
Total 2 0 0.02 0.00   
Parvimonas           
Parvimonas micra 15 1 0.36 0.02 SILVA 
Total 15 1 0.36 0.02 SILVA/HOMD 
Peptoniphilus           
Peptoniphilus 7 8 0.05 0.83   
Peptoniphilus duerdenii 1 0 0.03 0.00 SILVA/HOMD 
Peptoniphilus lacrimalis 1 0 0.04 0.00   
Total 9 8 0.13 0.83   
Peptostreptococcus           
Peptostreptococcus stomatis 8 2 0.11 0.02 SILVA 
Total 8 2 0.11 0.02 SILVA 
Porphyromonas         SILVA 
Porphyromonas 3 1 0.06 0.27   
Porphyromonas endodontalis 9 3 0.54 0.34   
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Porphyromonas gingivalis 1 0 0.01 0.00   
Porphyromonas pasteri 8 3 0.23 0.14 SILVA/HOMD 
Total 21 7 0.84 0.76 SILVA 
Prevotella         SILVA/HOMD 
Prevotella 19 7 2.18 0.76 SILVA/HOMD 
Prevotella baroniae 3 0 0.04 0.00 SILVA 
Prevotella conceptionensis 2 0 0.06 0.00 SILVA/HOMD 
Prevotella dentalis 3 0 0.05 0.00 SILVA/HOMD 
Prevotella denticola 2 1 0.00 0.06 SILVA/HOMD 
Prevotella disiens 1 0 0.03 0.00 SILVA/HOMD 
Prevotella histicola 7 4 0.37 0.51 SILVA/HOMD 
Prevotella intermedia 2 1 0.19 0.54 SILVA/HOMD 
Prevotella loescheii 3 0 0.02 0.00 SILVA/HOMD 
Prevotella melaninogenica 16 5 0.42 0.71 SILVA/HOMD 
Prevotella nanceiensis 6 3 0.07 0.07 SILVA/HOMD 
Prevotella nigrescens 9 3 0.70 0.15 SILVA/HOMD 
Prevotella oris 14 2 0.90 0.04 SILVA/HOMD 
Prevotella pallens 7 5 0.13 0.17   
Prevotella salivae 9 6 0.29 0.62   
Prevotella shahii 1 1 0.00 0.11   
Prevotella veroralis 0 1 0.00 0.07 SILVA/HOMD 
Total 104 39 5.45 3.81 SILVA/HOMD 
Rothia           
Rothia 5 5 0.02 1.22   
Rothia dentocariosa 12 6 0.06 1.12   
Rothia mucilaginosa 10 5 0.10 0.55 SILVA 
Total 27 16 0.19 2.88 SILVA 
Selenomonas         SILVA/HOMD 
Selenomonas 12 4 0.13 0.28 SILVA 
Selenomonas artemidis 2 1 0.02 0.00   
Selenomonas infelix 2 0 0.02 0.00   
Selenomonas noxia 4 0 0.17 0.00 SILVA/HOMD 
Selenomonas sputigena 7 2 0.03 0.05   
Total 27 7 0.38 0.33   
Solobacterium           
Solobacterium moorei 3 2 0.01 0.04 HOMD 
Total 3 2 0.01 0.04 HOMD 
Streptococcus         HOMD 
Streptococcus 31 16 5.60 6.00 SILVA 
Streptococcus anginosus 3 1 0.02 0.00 HOMD 
Streptococcus constellatus 2 1 0.02 0.25 HOMD 
Streptococcus intermedius 8 1 2.80 0.01   
Streptococcus oralis 3 0 0.04 0.00   
Streptococcus pneumoniae 15 2 8.76 0.12 SILVA/HOMD 
Streptococcus sanguinis 10 2 0.04 0.27   
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Total 72 23 17.29 6.65   
Tannerella           
Tannerella forsythia 7 1 0.12 0.02 HOMD 
Total 7 1 0.12 0.02 SILVA 
Treponema         SILVA 
Treponema 3 0 0.06 0.00 SILVA/HOMD 
Treponema denticola 3 1 0.07 0.01 SILVA/HOMD 
Treponema lecithinolyticum 1 1 0.00 0.03 SILVA 
Treponema medium 2 2 0.03 0.19   
Treponema putidum 3 0 0.07 0.00   
Treponema socranskii 3 2 0.02 0.01   
Treponema vincentii 1 2 0.01 0.07 HOMD 
Total 16 8 0.27 0.31 HOMD 
Veillonella         HOMD 
Veillonella 23 10 1.86 2.87   
Veillonella dispar 15 5 0.12 1.09   
Veillonella parvula 14 8 0.30 0.65 HOMD 
Veillonella rogosae 10 3 0.13 0.28 SILVA/HOMD 






















† Taxonomic features are ASVs aggregated at the lowest level of classification available (genus or 






Figure 4.1 Bacterial diversity differs between CRS and non-CRS samples. (A) DPCoA 
ordination biplot shows dissimilarity in presence and abundance of bacteria in CRS and 
non-CRS samples. (B) Percent abundance of Actinobacteria is associated with non-CRS 
status (Wilcoxon, p<.0001). (C) Among CRS samples, percent abundance of 
Actinobacteria is associated with no prior FESS treatment (Wilcoxon, p<.05). (D) Percent 
abundance of Actinobacteria is negatively correlated with percent abundance of both 
Bacteroidetes and Fusobacteria. (E) Heat map representation of the top 15 genera in each 




Figure 4.2 Relative abundance of Bacterial phyla in CRS and non-CRS samples. The relative abundance of ASVs grouped by phylum are 






Figure 4.3 Carbohydrate active enzyme classes in PICRUSt2-predicted metagenomes from 
CRS and non-CRS 16S sequences. Average relative functional abundances of each enzyme 
class (EC) represented in the CAZy database for the top ten taxa by relative abundance in 
(A) CRS and (B) non-CRS samples. CAZy classes: Auxiliary Activity (AA), Carbohydrate 
Esterase (CE), Glycoside Hydrolase (GH), Glycoside Transferase (GT), and 





Figure 4.4 Anaerobic mucin enrichment cultures of CRS sinus mucus.  (A) Heatmap showing 
relative abundance of ASVs grouped at the genus level for each original sample and 
enrichment culture. (B) Mean relative abundances for the top 20 genera in original sample 
and enrichment culture. (C) DPCoA biplot comparing proportional data from original 
samples and enrichment cultures with associated phyla. (D) FPLC chromatogram of high 





Figure 4.5 S. aureus growth on mucin under aerobic and anaerobic conditions. S. aureus LAC 
grown in minimal mucin medium (MMM), supplemented with 0.5% casamino acids 
(MMMC), 0.5% lactate (MMML), 0.25% glucose (MMMG), or a combination of these 
(MMMLC, MMMGC). (A) growth curves measured under aerobic conditions, points 
represent the mean and standard deviation; n=3. (B) Growth measured at O.D.600nm after 
24 hours of growth under anaerobic conditions with and without the addition of 3mM 
nitrate; Data shown are the mean of n = 6 (MMM, MMMC, MMML, MMMLC), n=3 
(MMMG, MMGC) biological replicates; Error bars are s.d.; significance determined by t-





Figure 4.6. S. aureus growth on CFS from CRS mucin-degrading communities. (A) S. aureus 
LAC aerobic growth curves on CFS from CRS derived mucin-degrading communities. (B) 
S. aureus anaerobic growth after 24 hours in CFS from CRS derived mucin-degrading 
communities A-H with and without sodium nitrate (3 mM). Error bars are s.d.; significance 
determined by t-test with Holm-Bonferroni adjustment. (C) HPLC measurement of 
fermentation metabolites Acetate, Propionate, and Lactate in CFS A-H. (D) HPLC 
















Figure 4.7. RNA-seq reveals impact of mucin degradation and fermentation on S. aureus 
transcription. (A) Differential expression of genes (79 up, 14 down) in cell-free supernatant 
conditions from communities D, F, and H compared to MMMG controls. Wald test was 
used to assign significance for genes with |FC| > 2, and FDR adjusted p-value < 0.05. (B, 
C) Transcripts involved in sialic acid degradation and central metabolism were 
differentially increased in expression in supernatant conditions compared to glucose. (D) 
Select genes with significant differences between each CFS condition. Significance was 
determined using the likelihood-ratio test, keeping only genes with a |LFC| >2 and FDR 
adjusted p-value < 1x10-10. Data presented are differences from the mean for each gene 
calculated from regularized log-transformed counts. All data are representative of three 
biological replicates per condition.
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Summary of research 
This thesis addresses the microbial ecology of bacteria associated with chronic 
rhinosinusitis (CRS). The heterogeneity of this disease complicates our understanding of 
bacterial contributions to pathogenesis. Genomic, bioinformatic, and classical 
microbiology techniques were used in this work to describe bacterial diversity in the 
sinuses, then make novel inferences into the functions carried out by microbiota in the CRS 
niche. 
The first section of this thesis focused on CRS in the cystic fibrosis (CF) population, 
where it is seen at a prevalence close to 100%. Chronic sinus colonization has been 
implicated as a source of pulmonary infections that are associated with loss of lung 
function, and the primary cause of morbidity and mortality in this population. In Chapter 
2, we explored the relationship of bacterial diversity in paired sinus and lung samples from 
CF patients. We demonstrated that there is high interindividual variability between 
bacterial communities across CF patients, and interestingly, many taxa are shared between 
the upper and lower airways. We also demonstrate that obligate anaerobes are prevalent in 
the CF lung. 
Since publishing this study in 2017, the topic of anaerobes in CF sputum has been 
the subject of a larger debate in the field (Caverly and LiPuma, 2018).The question of 
whether anaerobes identified in sputum are members of polymicrobial communities in the 
lungs of CF patients, or simply a byproduct of oral contamination during sputum collection 
remains controversial. A later study comparing bacterial communities of the sinuses and 
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lungs of CF patients instead used endoscopically obtained bronchial brushings, comparing 
their work to ours (Pletcher et al., 2019). The study did not confirm our results showing 
significant differences in diversity between grouped sinus and lung samples. However, the 
similarity in bacterial membership between the two sites within patients was again 
demonstrated. Moreover, bronchial brushings of recent lung transplants (LTx) showed 
increased diversity including the presence of anaerobic taxa. At 4.5 months post-transplant, 
one bronchial brushing showed little resemblance to a paired sinus sample, however the 
other sample pair, collected 9 months after LTx already showed presence of the dominant 
genus in the sinuses (Pseudomonas). Moving forward, sequential sampling of the upper 
and lower airways of CF patients will provide better insight into the relationship between 
the bacterial communities in each niche. Furthermore, the increased resolution in bacterial 
genomics afforded from metagenomic sequencing will enable strain-level tracking of 
bacteria within the airways, and how they are trafficked between sites. 
Further investigation of CF-CRS bacterial communities is presented in Chapter 3. 
Similar to Chapter 2, dominance of either Pseudomonas or Staphylococcus in each sample 
is apparent. Research into virulence mechanisms of these canonical pathogens have 
revealed a great deal about their physiology in vitro. Comparatively less attention has been 
paid to the polymicrobial context of the upper and lower airways in CF. We found an 
interesting result when comparing communities dominated by Pseudomonas, and 
communities dominated by Staphylococcus: Staphylococcus-dominated communities were 
more diverse. The prevalence of S. aureus and P. aeruginosa in the CF airways has been 
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associated with patient age, with S. aureus colonization occurring early in life, and P. 
aeruginosa becoming more prominent in adulthood (Cystic Fibrosis Foundation Patient 
Registry, 2019). Mechanisms that govern this transition are not well understood. Patterns 
in the data suggest there is an age-related relationship with diversity and Staphylococcus 
dominance, however a larger cohort will be needed to test this. Apart from the association 
with age, these data introduce the idea that interbacterial interactions of a more diverse 
community may influence S. aureus physiology and pathogenic potential, and community 
dominance in the chronically colonized sinuses. While not addressed in this thesis, the 
question has been posed by our group before (Flynn et al., 2016) that anaerobic organisms 
present in S. aureus-associated communities may also play a role in conditioning the 
airway niche for P. aeruginosa colonization of the upper airways – a process that is thought 
to precede pulmonary infection (Folkesson et al., 2012; Hansen et al., 2012). 
The final study presented in this thesis investigates how host-derived mucin 
glycoproteins support bacterial diversity in CRS. 16S rRNA sequencing, metagenomic 
prediction, and bioinformatic analysis led to the observation that there may be a mucin-
degrading bacterial phenotype in CRS. Using classical enrichment experiments to maintain 
metabolic dependencies, this study became the first to isolate mucin-degrading bacterial 
communities from CRS patient sinus mucus. Growth assays were paired with RNA-seq to 
demonstrate that the metabolic activities of mucin-utilizing communities influence S. 
aureus growth and gene transcription. Previous research investigating interbacterial 
interactions of S. aureus focused on pairs of co-abundant organisms such as P. aeruginosa, 
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Haemophilus influenzae, or Corynebacterium spp. (Filkins et al., 2015; Margolis et al., 
2010; Ramsey et al., 2016; Yan et al., 2013). Rarely is the physiology of S. aureus 
considered in response to the metabolic activities of bacterial consortia. This chapter 
reveals that the transcription of several genes involved in staphylococcal metabolism and 
virulence are differentially expressed in response to metabolites liberated from mucin 
degradation. These results form the basis for future experiments explicitly testing the effect 
of mucin degradation by anaerobic bacteria on S. aureus virulence.  
Future Directions 
Brooke et al. demonstrated the association of anaerobes with the progression of 
acute rhinosinusitis to CRS, yet this study has not been replicated either by culture or 
molecular methods (I Brook et al., 1996). Results presented in this thesis reiterate a need 
for longitudinal sampling of a large cohort of patients to overcome the heterogeneity seen 
in CRS and gain a better understanding of bacterial diversity changes over time. 
Additionally, a limitation of our work is that the methods only consider the bacterial 
component of microbial communities in the sinuses, although some research has shown 
that viral and fungal community members are associated with pulmonary exacerbations in 
CF (Kiedrowski and Bomberger, 2018; Soret et al., 2020). To date, there are no published 
metagenomic analyses of sinonasal microbiota. Future metagenomic analysis would allow 
for inclusion of fungal, viral, and archaeal detection providing a more comprehensive 
picture of CRS associated communities. 
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Our results demonstrate that mucin-degradation byproducts are able to improve S. 
aureus growth and alter gene transcription, however, it is unclear whether these happen in 
more physiologically relevant settings, and an impact on S. aureus virulence has not been 
explicitly tested. A first step would be to use a multi-omics approach to describe the 
taxonomic identities and transcriptional profiles of bacterial communities from CRS 
patients who are culture-positive for S. aureus. Metagenomic profiling of CRS sinus mucus 
will provide taxonomic identities that can be used to build a reference database. This 
database can then be used for metatranscriptomic comparison to test the hypothesis that 
mucinase gene expression is occurring in vivo. Furthermore, S. aureus genes identified in 
Chapter 4 as differentially abundant during growth on mucin degradation products can be 
verified in vivo. 
Our lab recently developed a respiratory anaerobic co-culture (RACC) system that 
can be used to study anaerobic bacteria at the epithelial cell surface (unpublished data). 
Using this model, we can test a variety of host-microbe co-culture scenarios that impact 
respiratory epithelial cells. First, while our research focused on how mucin-degradation by 
anaerobic bacteria impacts the physiology of S. aureus, it is important to test whether the 
metabolic byproducts of mucin degradation and fermentation are inflammatory to the host 
on their own. Mirkovic et al. reported a dose-dependent expression of pro-inflammatory 
cytokine IL-8 in response to short chain fatty acids in conventional bronchial epithelial cell 
culture (Mirković et al., 2015). Using the RACC experimental model, anaerobic mucin-
degrading communities isolated from CRS sinuses can be applied to the anoxic apical 
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surface of the cells, and mucin integrity, epithelial cell tight junction integrity, cell viability 
and inflammatory signaling can be measured using methods established in our lab. 
These proposed experiments will produce baseline knowledge for how polarized, 
differentiated respiratory cells react to mucin degradation. Building upon this knowledge, 
we can use the RACC experimental system again, but include a S. aureus challenge 
following growth of mucin-degrading consortia. In addition to the variables of epithelial 
cell layer integrity listed above, RNA-seq can be used to measure both host cell 
inflammation and S. aureus virulence gene transcription. Altogether, these experiments 
will contribute an in vivo perspective to complement the research presented in this thesis, 
and provide mechanistic detail to the pathogenic contribution of anaerobic bacteria to CRS. 
Concluding Remarks 
 Work presented here combines molecular based surveys, bioinformatics, and 
classical microbiology techniques to better understand the biology of understudied 
members of CRS-associated microbiota. This research stresses the need for future research 
to incorporate systems biology approaches to understanding bacterial pathogenesis in 
chronic infections. 
 Importantly, studying how CRS-associated anaerobes impact the pathogenic 
potential of S. aureus has implications for other types of chronic infections where it is also 
the dominant organism. For example, an analysis of 2,963 chronic non-healing wound 
patients established that, compared to P. aeruginosa, when S. aureus was the dominant 
organism it was accompanied by increased diversity of bacteria in the polymicrobial 
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biofilm, including many of the same anaerobe genera seen in CRS (Wolcott et al., 2016). 
Corollaries like this suggest that there are likely important interactions between S. aureus 
and anerobic bacteria that promote chronic infection in varied sites of infection. Further 
investigation of the intriguing relationships between S. aureus and comparatively less well 
studied anaerobic bacteria are needed.  
 Where our understanding of the pathogenic potential of organisms like S. aureus 
and P. aeruginosa are increasingly well understood, the physiology of many anaerobic 
bacteria is comparatively less well studied. The requisite laboratory cultivation that enabled 
such great strides in understanding the biology of these aerobic pathogens inherently 
disrupts microbial metabolic relationships that may be essential to understanding the 
biology of polymicrobial communities with anaerobe constituents. However challenging, 
further study of these organisms is warranted by their involvement in chronic infections in 
CRS and elsewhere. Just as the classical “Staph Streak” procedure enables Haemophilus 
isolation, microbiological methods such as enrichment and co-culture may be essential to 
reveal novel and medically important bacterial interactions and reveal unrealized biological 
diversity. To this end, the inclusion of complex glycoproteins such as mucins, which 
support diverse and discrete microbial metabolic niches should be considered in media 
preparation when studying members of the airway microbiome in isolation or in 
communities. Additionally, recently developed high resolution imaging techniques 
incorporating multiplexed fluorescent staining (e.g. CLASI-FISH) can provide great 
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insight into spatial organization of polymicrobial communities (Valm et al., 2011). These 
imaging methods have not yet been applied to study microbiota in CRS. 
 Finally, it is tempting to extend what has been learned here to propose antibiotic 
therapies for CRS, and indeed other chronic infections, that target anaerobes. However, it 
is becoming increasingly clear that a loss in microbial diversity and pathogen dominance 
is associated with increased disease burden in CRS. Moreover, antibiotic resistance is 
already seen widely in anaerobic bacteria(Hecht, 2004). With the known efficacy of FESS, 
sinus drainage, and debridement, and the microbiology associated with its failure of these 
treatments, other regimens should be explored that combine destabilization the low-oxygen 
infection site, while re-establishing microbial diversity associated with health. Use of 
probiotic therapies to treat CRS and other airway infections such as asthma and COPD is 
an active area of investigation. 
 CRS is a complex disease. If we are to understand the nature of the microbial 
contribution to CRS pathogenesis, we must build upon decades of reductionist 
microbiological research to make meaningful mechanistic hypotheses that don’t exclude 
bacterial interactions with each other and the surrounding infection microenvironment. 
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Table S1. Summary of subject clinical data 







1 M 25 FX 60 21   
Yes 
2 M 31 FF 54 41 Yes(2) Yes 
3 M 28 FF 77 21   Yes 
4 M 42 FF 50   Yes(4) Yes 
5 M 31 FF 76 20 Yes(2) Yes 
6 M 26 G551D/2789+5G>A 86 8   Yes 
7 F 19 F−G 71 50 Yes(4)   
8 F 26 F−G 72 59 Yes(1) Yes 
9 F 32 FF 51 34 Yes(1) Yes 
10 M 41 
1717-1G-
7A/3849+10kbc-T1 
76 23 Yes(1) Yes 
11 F 36 FF 70 36 Yes(1)   
12 M 31 Fdel 54 58 Yes(3) Yes 



























1 Streptococcus - - - - - - - 
2 Staphylococcus - + - + - - - 
3 Pseudomonas - ++ - + - - - 
4 Pseudomonas - ++ ++ - - - - 
5 Staphylococcus - - - - - - ++ 
6 Staphylococcus - - +++ - - - - 
7 Staphylococcus NA NA NA NA NA NA NA 
8 Pseudomonas + - + - - - - 
9 Pseudomonas - + - + - - - 
10 Burkholderia - - - - - ++ - 
11 Staphylococcus - + +++ (MRSA) - - - - 
12 Pseudomonas - +++ +++ (MRSA) - - - +++ 






















1 NA ++ ++ - - - - - 
2 Pseudomonas + + +++ - - - - 
3 Pseudomonas +++ + - - - - - 
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4 NA ++ - +++ - - - - 
5 NA - - - - - - - 
6 NA NA NA NA NA NA NA NA 
7 Staphylococcus - - + - - - - 
8 NA - - +++ - - - - 
9 NA ++ - - - - - - 
10 NA - - - - - ++ - 
11 NA - ++ +++ (MRSA) - - - - 
12 Pseudomonas - + +++ (MRSA) - - - ++ 





Table S3. Spearman correlations between bacterial genera in sample pairs 
Sample Pair Correlation coefficient Nonparametric p-value CI (lower) CI (upper) 
1 0.3422 0.014 0.0736 0.5646 
2 0.2542 0.065 -0.023 0.4951 
3 0.6692 0.001 0.4826 0.7977 
4 0.7089 0.001 0.5385 0.8236 
5 0.3489 0.012 0.0811 0.5697 
6 0.1056 0.473 -0.1751 0.3704 
7 0.4129 0.003 0.155 0.6181 
8 0.6026 0.001 0.3921 0.7531 
9 0.2869 0.027 0.0123 0.5213 
10 0.2862 0.043 0.0116 0.5207 
11 0.3089 0.022 0.0364 0.5386 




Table S4. Antibiotics and route of delivery prescribed three days prior to FESS surgery. 
Patient Azithromycin Cayston Colistin Tobramycin Doxycycline Gentamicin Ciprofloxacin Bactrim Amoxicillin 
1 Oral Inhalation  -   -   -   -  Oral  -   -  
2 Oral Inhalation  -   -   -   -   -   -   -  
3 Oral  -   -  Oral  -   -   -   -   -  
4  -   -   -   -   -   -   -   -   -  
5  -   -  Inhalation  -   -   -   -   -  Oral 
6  -   -   -   -   -  Intravenous  -   -   -  
7 Oral  -   -  Inhalation  -   -   -  Oral  -  
8 Oral Inhalation Inhalation  -   -   -   -   -   -  
9 Oral Inhalation  -  Inhalation  -   -   -   -   -  
10 Oral  -   -  Inhalation  -   -   -   -   -  
11 Oral Inhalation  -   -  Oral  -   -   -   -  







Figure S1. KEGG Pathways identified in sinus and lung samples through PICRUSt analysis. KEGG 
pathways represented in PICRUSt predicted metagenomes (>1%) exhibited similar composition and 
abundance between sinus and lung samples. Common predicted pathways between sinus and lung niches 
belong to bacterial secretion systems, and ABC transporters. 



















































Chromosome Replication and Repair



















Quantitative PCR. Bacterial burden was estimated by quantifying 16S copy number from DNA 
extracted from clinical specimens using qPCR. Universal 16S rRNA qPCR primers 338F and 518R 
were used (36, 37). QuantiTect SYBR Green (Qiagen, Valencia, CA) was used according to 
manufacturer’s instructions. Reactions were prepared in triplicate as described previously, with 
adjustments to the amplification protocol (22). Briefly, reactions (25 μL) each contained 12.5 μL 
2X QuantiTect SYBR Green Master Mix, 2.5 μL each of 3 μM forward and reverse primers, and 
6.5 μL H2O. Each sample was diluted to 10ng/μl and 1 μl of each of these dilutions was added to 
their respective reactions. Amplification was done using a CFX96 Real-Time PCR System (Bio-
Rad, Hercules, CA) with the following cycling conditions: 95˚C for 15 min followed by 40 cycles 
of 94˚C for 15 s, 55˚C for 30 s, 72˚C for 30 s with data acquisition at 72˚C. Quantification cycle 
(Cq) values were calculated using instrument software (CFX Manager, v.3.1). A standard curve 
with a range from 5x106 to 5x102 16S rDNA gene copies was used for quantification of 16S copy 
number and prepared using serial dilutions of DNA extracted from a pure culture of Escherichia 
coli MG1655 (ATCC 47076), known to have seven 16S rDNA gene copies per genome. 
 
DNA extraction, Library Preparation, and Sequencing. The Powersoil DNA Isolation Kit 
(MoBio, Carlsbad, CA) was used to extract genomic DNA from 300 µL of mucus, following the 
manufacturer’s protocol. Purified DNA was submitted to the UMN Genomics Center (UMGC) for 
16S library preparation using a two-step PCR protocol (23). The V4 region of the 16S gene was 
amplified and sequenced on an Illumina MiSeq using TruSeq version 3 2x300 paired-end 
technology. Water and reagent control samples were also submitted for sequencing and did not pass 
quality control steps due to 16S rRNA gene content below detection thresholds. Raw 16S rRNA 
gene sequence data were deposited as fastq files in the NCBI Sequence Read Archive under 
accession number PRJNA374847.  
 Sequence analysis. Sequence data were obtained from UMGC and analyzed using a 
pipeline developed by the UMN Informatics Institute in collaboration with the UMGC and the 
Research Informatics Solutions (RIS) group at the UMN Supercomputing Institute (38). Briefly, 
this pipeline implements Trimmomatic (39) to trim Illumina TruSeq adapter sequences using 
default options, followed by PANDAseq (40) to align paired-end reads. Consensus sequences were 
then clustered into operational taxonomic units (OTUs) at 97% identity to the Greengenes database 
(v.13.8) (41), through implementation of the pick_open_reference_otus.py script with the 
usearch61 algorithm provided through the Quantitative Insights Into Microbial Ecology (QIIME) 
software (v.1.9.1) (42).  
 The OTU table was then filtered such that only OTUs present in the Greengenes database 
were evaluated. OTUs representing less than 0.005% relative abundance in each sample were 
excluded as were OTUs representing mitochondrial and plastid sequences. The median number of 
sequences/sample at this stage was 59774 (interquartile range (IQR)=25002-124256). For 
calculation of alpha diversity metrics and ordination for principal coordinates analysis, sequences 
were subsampled to 1674 reads per sample. For principal coordinates analysis, count data in the 
OTU table was transformed to proportions of the total sequences in each sample. Permutational 
analysis of variance (PERMANOVA) and homogeneity of dispersion tests were carried out using 
the ‘adonis’, ‘betadisper’, and ‘permutest’ functions in the ‘vegan’ R package (43). 
 Prediction of sinus and lung metagenomes based on 16S rRNA data. Metagenomes were 
inferred from 16S rRNA data using Phylogenetic Investigation of Communities by Reconstruction 
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of Unobserved States (PICRUSt) (v. 1.0.0) (24). PICRUSt uses marker gene survey data to predict 
metagenome functional content of microorganisms through ancestral state reconstruction. We 
implemented PICRUSt scripts to infer metagenomes from the quality filtered OTU table. Briefly, 
OTUs were normalized by 16S copy number using the script normalize_copy_number.py. 
Normalized OTUs were used to predict KEGG orthology (KO)-based metagenomes of our samples 
through input into the script predict_metagenomes.py with an additional per-sample Nearest 
Sequenced Taxon Index (NTSI) calculation. Finally, predicted metagenomes were further 
categorized by KEGG pathways using the categorize_by_function.py script. Output of this script 
was filtered to only include those pathways that accounted for 1% of count data in each sample.  
 We then used BugBase (https://bugbase.cs.umn.edu) to summarize predicted metagenomes 
by bacterial phenotype. BugBase combines functionalities of PICRUSt, Integrated Microbial 
Genome comparative analysis system (IMG4) (44), the PATRIC bacterial bioinformatics database 
(45), and the KEGG database (46), to identify specific OTUs that contribute to a community-wide 
phenotype. The main script was run with default settings using the same filtered OTU table as used 
in PICRUSt. BugBase implements the non-parametric Wilcoxon matched-pairs signed rank test to 
assess significance. Within-patient and between-sample type taxonomy correlations were 
calculated using the QIIME script compare_taxa_summaries.py using Spearman correlation with 
999 permutations (42).  
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Appendix B:  Bioorthogonal non-canonical amino acid tagging reveals translationally 
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 Culture-independent studies of cystic fibrosis lung microbiota have provided few 
mechanistic insights into the polymicrobial basis of disease. Deciphering the specific contributions 
of individual taxa to CF pathogenesis requires comprehensive understanding of their ecophysiology 
at the site of infection. We hypothesize that only a subset of CF microbiota are translationally active 
and that these activities vary between subjects. Here, we apply bioorthogonal non-canonical amino 
acid tagging (BONCAT) to visualize and quantify bacterial translational activity in expectorated 
sputum. We report that the percentage of BONCAT labeled (i.e. active) bacterial cells varies 
substantially between subjects (6-56%). We use fluorescence-activated cell sorting (FACS) and 
genomic sequencing to assign taxonomy to BONCAT-labeled cells. While many abundant taxa are 
indeed active, most bacterial species detected by conventional molecular profiling show a mixed 
population of both BONCAT labeled and unlabeled cells, suggesting heterogeneous growth rates 
in sputum. Differentiating translationally active subpopulations adds to our evolving understanding 





 The increased viscosity and impaired clearance of mucus secretions in cystic fibrosis (CF) 
airways creates a favorable environment for chronic microbial colonization, the primary cause of 
morbidity and mortality (1). Pseudomonas aeruginosa and Staphylococcus aureus have long been 
recognized as primary CF pathogens and are the targets of common therapeutic regimens (2), 
though recent culture-independent studies have revealed a more complex polymicrobial community 
harboring facultative and obligately anaerobic bacteria that are relatively understudied (3–5). While 
the specific contributions of individual community members to disease progression remain poorly 
understood and at times controversial (6), cross-sectional studies of both pediatric and adult cohorts 
have revealed compelling relationships between bacterial community composition and disease 
stage, antibiotic use, age, and other phenotypes (7–12). These data have challenged the field to 
reconsider therapeutic strategies in a polymicrobial community context (13,14).  
 Relatively fewer studies have identified within-subject perturbations in bacterial 
community structures that coincide with acute and complex disease flares known as pulmonary 
exacerbations (PEx). Though no standardized definition of PEx is broadly accepted (15), these 
episodes are generally characterized by increased respiratory symptoms (e.g., shortness of breath, 
sputum production) and acute decreases in lung function that can, but not always, be resolved in 
response to antibiotic therapy. While this would suggest a bacterial etiology, sputum cultures 
generally demonstrate that airway pathogens are recovered at similar densities before, during, and 
after disease flares (16–19). Culture independent studies show similar trends; with exceptions 
(9,20–22), longitudinal sequencing analyses of sputum from individual subjects frequently reveal 
unique, subject-specific bacterial communities whose diversity and composition remain stable 
during PEx onset and upon resolution of disease symptoms (16,23,24). This lack of association 
between lung microbiota and disease dynamics may reflect the inability of both culture-based and 
sequencing approaches to capture changes in bacterial activity, which likely have a critical impact 
on disease progression and therapeutic effectiveness. 
 To date, there have been few studies of bacterial growth and metabolism within the CF 
airways (25–30). RNA-based profiling of stable CF subjects has shown consistencies between RNA 
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and DNA signatures suggesting that many bacterial taxa identified by 16S rRNA gene sequencing 
are metabolically active, though these data have also corroborated that bacterial community 
membership is not necessarily predictive of growth activity (25,26). Further, rRNA/DNA ratio 
methods are inherently constrained for use on complex bacterial communities with varying growth 
strategies (i.e., human microbiota) (31,32). Interactions between respiratory pathogens and the host 
and/or co-colonizing microbiota can influence growth rates, metabolism, virulence factor 
production, and antimicrobial susceptibility without an accompanying change in bacterial 
abundance (33–38). And finally, growth rates of respiratory pathogens can vary substantially 
between subjects and even within a single sputum sample (27,28), the heterogeneity of which is 
not captured using conventional molecular profiling. There remains a need for novel methods to 
characterize bacterial activity and its role in disease progression. 
 Bioorthogonal non-canonical amino-acid tagging (BONCAT) has been used to 
characterize the activity of uncultured microbes in soil and marine samples (39–43). BONCAT 
relies on the cellular uptake of a non-canonical amino-acid (e.g., L-azidohomoalanine (AHA), a L-
methionine analog) carrying a chemically-modifiable azide group (44). After uptake, AHA exploits 
the substrate promiscuity of methionyl-tRNA synthetase and is incorporated into newly synthesized 
proteins. Translationally active cells can then be identified through a bioorthogonal azide-alkyne 
click reaction in which a fluorophore-tagged alkyne is covalently ligated to AHA, resulting in a 
fluorescently labeled population of translationally active cells that can be further studied using a 
variety of microscopy and analytical methods.  
 BONCAT has been shown to correlate with other established methods of quantifying 
microbial activity (40,43) and represents a robust tool for characterization of bacterial communities 
and a range of other organisms in their native growth environment. BONCAT has also recently 
been used to study bacterial pathogens in vitro (45–48), though it has seen limited use in the study 
of host-associated bacterial communities (40,49). Samples derived from the CF airways provide a 
unique opportunity to do so, as the site of infection is amenable to longitudinal studies and the 
bacterial growth environment is relatively stable upon removal from the host (50). Exploiting these 
advantages, here we use BONCAT together with imaging, fluorescence-activated cell sorting 
(FACS) and 16S rRNA gene sequencing to characterize the translational activity of bacterial 
communities within sputum derived from a cohort of seven clinically stable CF subjects. We reveal 
that active bacteria represent only a subset of microbiota captured using conventional 16S rRNA 





BONCAT differentiates translationally active bacteria 
 
 To optimize the BONCAT experimental approach, we first grew P. aeruginosa, a canonical 
CF pathogen, to mid-log phase followed by supplementation with 6 mM L-azidohomoalanine 
(AHA) for 3h. Post-AHA treatment, azide-alkyne click chemistry using Cy5-labeled 
dibenzocyclooctyne (Cy5–DBCO), permitted fluorescent detection of translationally active cells 
(Fig. 1a). Quantification of average Cy5 pixel intensity per cell revealed active protein synthesis in 
~98% of the population. By contrast, supplementation of the growth medium with 6 mM L-
methionine (MET) or pretreatment of P. aeruginosa with tobramycin, chloramphenicol, and 
tetracycline (to arrest de novo protein synthesis) prior to AHA resulted in negligible fluorescence 
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(Fig. 1b, c). These data were also confirmed by SDS-PAGE (Supplementary Fig. 1). Finally, when 
two AHA-labeled cultures (one treated with antibiotics, one without) were combined in a 1:1 ratio 
prior to Cy5–DBCO labeling, a bimodal distribution of fluorescence intensities were observed, 
representing a mix of active and inactive cells (Fig.1d). Together, these data demonstrate the utility 
of BONCAT for characterizing P. aeruginosa translational activity in an amino-acid-rich growth 
environment. 
 To assess whether BONCAT is broadly suitable for labeling polymicrobial communities 
found in the airways, we then performed mixed activity labeling as described above on 
representative isolates of common CF-associated microbiota;(51) Achromobacter xylosoxidans, 
Burkholderia cenocepacia, Escherichia coli, Fusobacterium nucleatum, Prevotella 
melaninogenica, Rothia mucilaginosa, Staphylococcus aureus, Stenotrophomonas maltophilia, 
Streptococcus parasanguinis, and Veillonella parvula (Fig. 2). Each mixed culture (+/−antibiotics 
in a 1:1 ratio) exhibited a similar labeling pattern to P. aeruginosa, suggesting that BONCAT can 
be used to characterize translational activity among diverse bacterial taxa associated with the CF 
airways. Notably, all species tested demonstrated BONCAT labeling. In addition, AHA did not 
affect the growth phenotype of any species under our experimental conditions (Supplementary Fig. 
2), consistent with previous studies showing that BONCAT permits labeling of microbiota without 
concomitant changes in growth rate or protein expression (40,52). 
 
 
BONCAT identification of active CF microbiota 
 
 The BONCAT protocol optimized for lab-grown cultures was then modified for analysis 
of CF bacterial communities in sputum. To do so, sputum was collected from clinically stable 
subjects and immediately supplemented with cycloheximide to reduce AHA incorporation by host 
cells (Supplementary Fig. 3). Samples were then divided into three equal-volume aliquots, 
supplemented with either 6 mM AHA, 6 mM methionine, or antibiotics (30 µg mL−1 
chloramphenicol, 200 µg mL−1 tetracycline, and 10 µg mL−1 tobramycin) plus 6 mM AHA, and 
incubated at 37°C under oxic conditions for 3 h. Incubation time was chosen to maximize labeling 
while minimizing changes in bacterial growth conditions such that they closely reflected the in vivo 
chemical environment. AHA concentration (6 mM) was based on average methionine content in 
CF sputum (0.6 mM) (53) and a 10:1 AHA:MET ratio (or greater) required for effective labeling 
(Supplementary Fig. 4). 
 Representative micrographs (Fig. 3a) reveal BONCAT-labeled sputum obtained from three 
individual CF subjects (Supplementary Table 1, subjects 1–3). Consistent with previous reports of 
heterogeneous growth rates (27,28,54), notable differences in Cy5 fluorescence are apparent at 
higher magnification (Fig. 3b); several individual cells and cell aggregates show moderate to 
intense labeling whereas others are unlabeled. Treatment with methionine instead of AHA did not 
result in fluorescent signal, ruling out non-specific labeling and residual dye that could not be 
removed by washing (Supplementary Fig. 5). Similarly, treatment of sputum with antibiotics prior 
to AHA addition also resulted in a significant reduction in fluorescence intensity. However, this 
reduction was incomplete, which may reflect the development of antimicrobial tolerance that arises 
among CF pathogens. Finally, though cycloheximide treatment results in a significant reduction in 
AHA uptake by macrophages (Supplementary Fig. 3), we note that host-cell contributions to 
BONCAT fluorescence cannot be ruled out. Despite this possibility, average pixel intensity per cell 
(Fig. 3c) further emphasizes the range of bacterial translational activity and the likely slower growth 
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rates of CF microbiota in sputum compared to cultures grown in vitro (compare Fig. 3c and Fig. 
1a). These analyses demonstrate that BONCAT labeling can be used to characterize bacterial 
activity within complex sputum samples. Moreover, these data suggest that translationally active 
bacteria represent only a subpopulation of the CF lung microbiota. 
 
Flow cytometric analysis of BONCAT-labeled CF microbiota 
 
 BONCAT combined with fluorescence-activated cell sorting (FACS) has previously been 
used to study microbial activity within soils and marine sediments (39,42). We therefore sought to 
use FACS to characterize and isolate BONCAT-labeled (i.e., active) cells and bacterial aggregates 
within sputum samples derived from clinically stable CF subjects (Supplementary Table 1, Subjects 
4–6). Our experimental workflow is shown in Fig. 4. Upon sputum collection, a small aliquot 
(original) was removed and stored at −80°C prior to conventional 16S rRNA gene amplicon 
analysis. Remaining sputum was then treated with cycloheximide and divided into four aliquots, 
three of which were supplemented with AHA (6 mM). As a control, the remaining aliquot was 
treated with 6 mM methionine, and all samples were then incubated under oxic conditions at 37 °C 
for 3h. Samples were subjected to Cy5–DBCO labeling and counterstaining, followed by removal 
of another aliquot (sort input) to determine community profile changes as a result of chemical 
fixation and sputum incubation ex vivo. Remaining samples were homogenized and filtered to 
remove host cells, followed by FACS to isolate Cy5− (sort-negative) and Cy5+ (sort-positive) cells. 
 Given the potential heterogeneity of a single sputum plug, triplicate aliquots from each CF 
sputum sample were BONCAT-labeled and analyzed by FACS and 16 S rRNA gene sequencing 
to assess the consistency of results (Supplementary Figs. 7 and 8). Representative FACS plots are 
shown in Fig.5a. Cy5−and Cy5+ gates were sample-specific and were established first by using an 
AHA−(MET+) aliquot to define the negative gate for each sample. Positive gates were then 
conservatively assigned by comparing the AHA+ aliquots to the AHA− control (see Supplementary 
Fig. 9 for gating scheme). AHA+ samples underwent notable shifts along the Cy5+ axis (Fig. 5a) 
and cells that fell within the Cy5+ gate exhibited a higher geometric mean off fluorescence intensity 
in the Cy5 channel (Supplementary Fig.10). These data confirm BONCAT labeling and are 
reflective of translational activity (Fig. 5a). Sort specificity was validated by immunostaining using 
an anti-Cy5 antibody, which revealed estimated false-negative and false-positive rates of 6.8% and 
12%, respectively (Supplementary Fig. 6). Based on total events (~6.5 million counts per sample, 
on average; Supplementary Table 2), we consistently found that only a subset of the overall 
bacterial population was Cy5+. For the three individuals surveyed, replicate averages of the Cy5-
labeled population were 6.2% (+/−1.21), 42.6% (+/−5.62), and 56.1% (+/−9.57) for subjects 4,5, 
and 6, respectively. These data reflect labeling patterns shown by microscopy (Fig. 3) and suggest 
that expectorated sputum harbors bacterial communities with a range of translational activity. 
 
Taxonomic identities of active sputum microbiota 
 
 16S rRNA gene sequencing was applied to original, sort input, sort-negative, and sort-
positive fractions from each sample to determine bacterial community composition. Sequence data 
were analyzed using the DADA2 pipeline (55) to reduce potential loss of biological sequence 
variation due to clustering by similarity and to improve observation of fine-scale variation 
(including species-level resolution) in bacterial populations. Using this approach, sequence data 
derived from AHA-labeled samples (sort input, sort-negative, and sort-positive) were compared to 
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their paired original sample to characterize translationally active subpopulations. For each subject, 
sample replicates were compared by proportions of the top-ranking taxa (Supplementary Fig. 8a), 
and variation related to sample type was visualized using a double principle coordinates analysis 
(DPCoA) (Supplementary Fig. 8b). Replicate samples showed considerable agreement, thus, 
relative abundances were averaged for further analysis. 
 Each subject harbored lung microbiota of low to moderate complexity (Fig. 5b), and 
community profiles were consistent with prior 16S rRNA gene surveys of CF sputum in which 
Pseudomonas and Streptococcus were dominant genera (3–5,9–12). We also achieved species-level 
resolution for less abundant taxa, including several obligate and facultative anaerobes (e.g., 
Prevotella sp., Rothia sp.). In general, AHA labeling did not result in substantial changes in 
bacterial membership; for the most abundant taxa (>1%), community composition was comparable 
before (original) and after (sort input) BONCAT labeling, demonstrating that AHA treatment and 
chemical fixation had minimal effect on relative bacterial abundance. Interestingly, bacterial 
populations recovered from BONCAT–FACS analysis (sort-negative, sort-positive) also showed 
similarities among the most abundant community members relative to the original sample (i.e., 
those detected by conventional 16S rRNA gene sequencing). Notable exceptions were 
Staphylococcus aureus and Rothia sp. for subject 4, which despite efficient labeling in laboratory 
culture, were of negligible abundance in the positive fraction, suggesting low translational activity. 
Less abundant taxa (Supplementary Fig. 11), showed greater variation between fractions, but most 
were also generally detectable in both sort-negative and sort-positive gates. Together, these data 
suggest that a subset of most taxa detected by conventional 16 S rRNA gene sequencing are 
translationally active. Moreover, each taxon appears to exhibit heterogeneous growth activity, 
which may have important implications for the progression and treatment of CF disease. 
 To better observe changes in the relative abundances of translationally active bacterial taxa, 
we calculated fold-change differences between sort-negative, sort-positive, and sort input fractions 
for each subject (Fig. 5c and Supplementary Figs. 12 and 13). Some genera/species present in fold-
change plots do not appear in taxa plots (Fig. 5b) because they were less than 1% relative 
abundance, but we note that activity among these less abundant populations may also be 
determinants of CF pathogenesis. In general, ranks of relative abundance were not appreciably 
different between sort-positive and sort-negative fractions (denoted by heatmaps in Fig. 5c). The 
most abundant organism in all subjects, Pseudomonas (ASV1/ASV4), was always in greater 
relative abundance in the positive sort (Fig. 5c), reflecting its active growth in sputum and 
underscoring its recognized importance as a CF pathogen. However, this trend of agreement 
between relative abundance and fold-change did not always hold. For example, Leptotrichia 
(ASV5) in subject 6 was high in rank abundance (see heatmaps), but its fold difference between 
positive and negative fractions was 0.22 (~4.5-fold greater in the negative sort), indicating lower 
relative translational activity than its co-colonizing microbiota. This was also observed for 
Streptococcus (ASV2) in subject 4, which was the second most abundant taxon yet showed low 
translational activity. Conversely, some low abundance organisms were in higher relative 
abundance in the positive sort. Most notably, Streptococcus (ASV12) and Rothia dentocariosa 
(ASV37) in subject 5 had average relative abundances of 1.3% and 2.3%, respectively, in the 
negative sort, but were 4.5- and 5.25-fold more prominent in the positive fraction. Other low 
abundance ASVs assigned as Actinomyces, Enterococcus, Peptostreptococcus, and 
Capnocytophaga sputigena showed similar trends, which were also confirmed by additional 
comparisons between sort-input/sort-positive and sort-input/sort-negative fractions (Supplemental 
Figs. 12 and 13). 
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 Taken together, these BONCAT data reveal the extensive heterogeneity of translational 
activity among CF microbiota. Each individual harbors a unique bacterial community, though 
community membership and relative abundance are not necessarily predictive of translational 
activity. Ultimately, profiling of bacterial communities in this manner may help guide therapeutic 




 16S rRNA gene sequencing has become the gold standard for culture-independent 
characterization of CF airway bacterial communities. Despite the wealth of data that have emerged 
regarding the complexity of lung microbiota, we have little understanding of bacterial activity at 
the site of infection and the specific contributions of individual species to pathogenesis. Expanding 
on recent studies employing BONCAT as a means of characterizing the ecophysiology of microbial 
communities in their natural growth environment (39–43), we use this approach in combination 
with FACS and 16 S rRNA gene sequencing to shed light on bacterial activity in CF sputum. We 
demonstrate that only a subset of each taxon is detectable by metabolic labeling. Identification and 
characterization of this subpopulation is not achievable using conventional sequencing approaches 
and may provide a more precise representation of relevant microbiota within the CF lung. 
 BONCAT-based studies of translationally active bacteria challenge our thinking on the 
microbial ecology of the CF airways. Each subject harbored a unique bacterial community 
consisting primarily of canonical lung pathogens (e.g., Pseudomonas). Consistent with previous 
studies using RNA-based methods (25,26), BONCAT–FACS-based sequencing data indicate these 
most abundant taxa are also active in situ, reinforcing a probable role for these genera in CF 
pathogenesis. However, we also revealed that low abundance community members not commonly 
associated with CF lung disease comprise many taxa that exhibited increased abundance in the 
positive sort, indicating that community membership is not always predictive of translational 
activity. In conventional 16S rRNA datasets, rare taxa (i.e., <1%) can be challenging to detect 
among high abundance organisms (or they are commonly grouped into an ‘other’ category). 
Moreover, longitudinal dynamics among low abundance taxa can be masked in standard taxa plots 
and may explain why observed within-subject differences in bacterial community composition 
rarely track with disease symptoms (9,16,23). While we cannot rule out that some AHA-negative 
cells are a result of impaired AHA uptake or instrument detection limits, our data suggest that dead 
and/or dormant biomass comprise a substantial proportion of sequence reads generated via 16S 
rRNA gene sequencing of CF sputum. We hypothesize that low abundance organisms represent 
keystone members of the lung microbiota, whose activity dynamics are determinants of acute 
inflammation, either by directly impacting the host, or indirectly through modulating the growth 
and virulence of higher abundance pathogens. 
 BONCAT imaging of sputum and fold-change plots between sort-positive and sort-
negative fractions demonstrated both population-wide and taxon-specific translational 
heterogeneity. This spectrum of metabolic states may confer a significant advantage for bacteria 
and optimize their fitness in the complex environment of the CF lung. In vivo, airway microbiota 
face a dynamic milieu shaped by microbial competitors, antimicrobials, the host immune response, 
nutrient limitation, and other chemical stimuli that can be unfavorable to growth. Under these 
conditions, adopting a bet-hedging strategy in which only a subpopulation of cells is active may 
ensure that a given bacterial species is prepared to contend with environmental stress (56). In 
addition, the transition between translationally active and dormant states may help to explain the 
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periodicity of PEx, faced with a favorable growth environment, more cells of a given taxon (or 
taxa) may be induced into active growth and elicit a heightened host response. 
 The balance between growth states may also be a critical determinant of host response to 
therapy. By adopting a persister-like strategy in which reduced cellular activity confers a temporary 
multidrug-resistant phenotype, a dormant subpopulation could ensure persistence during an 
antibiotic challenge. Once antibiotic-selective pressure is relieved, antimicrobial tolerant 
populations may emerge. This heterogeneity may also help explain instances in which a subject’s 
clinical response is not predicted by the in vitro drug susceptibility of a given pathogen. We posit 
that clinical sensitivity panels are poorly predictive of antibiotic efficacy because, among other 
limitations, they do not account for the heterogeneous translational activity described here. 
 While active cells are likely more responsible for pathogenesis, inactive cells (Cy5−) are 
also of importance to CF lung disease as bacteria do not necessarily have to be translationally active 
to influence their greater community. For example, it is known that largely dormant populations 
can drive geochemical processes in their growth environment (e.g., mineralizing organic carbon to 
CO2) (57–59). Translationally inactive cells can also shape their growth environment through 
nutrient exchange, secretion of virulence factors and small metabolites, electrostatic interactions, 
and stimulation of the host immune response. Further characterization of activity heterogeneity, the 
contributions of both active and dormant populations to disease, the frequency of transition between 
states and the factors that stimulate those transitions will help us to better understand disease 
dynamics and nature of these. 
 Though BONCAT represents a useful tool for the study of CF microbiota, we note 
limitations, several of which have been described previously (39,40,60). First, bacterial cell sorting 
by flow cytometry is imperfect, as each species has characteristic sort properties. When defining 
our gating scheme, Cy5+and Cy5−gates were conservatively chosen (requiring a gap in between 
gates) such that the selection of inactive cells in the positive gate was minimized, and vice versa. 
However, with this gap a subset of the active population is not collected. Similarly, there is a high 
probability of selecting active cells in the negative gate due to flow migration characteristics (e.g., 
F. nucleatum shifts differently than a much smaller V. parvula cell). Finally, bacterial aggregates, 
in which only some cells are active (see Fig. 3b) could be pulled into the negative gate by the 
inactive population of that aggregate. We are currently exploring alternative approaches, including 
optimization of gating strategies, to improve upon the sorting efficiency of BONCAT-labeled cells. 
 It is also possible that our experimental conditions were selective against certain taxa. As 
an example, the 3h AHA incubation is performed under oxic conditions, which may induce an 
aerobe bloom or inhibit less aero-tolerant bacteria ex vivo. Electrode analyses have shown that 
steep oxygen gradients are retained in expectorated mucus plugs and are stable over time (50), but 
it is notable that after AHA treatment, Rothia mucilaginosa (ASV8), Prevotella salivae (ASV30), 
Veillonella (ASV13), and other anaerobes were far more prevalent in the negative sort. However, 
this was not always the case (e.g., R. dentocariosa and S. wiggsiae increased in subjects 5 and 6) 
making it difficult to determine whether the observed fold-differences reflect growth constraints 
during BONCAT labeling or a true slow growth (or dormant) phenotype. Though each bacterium 
tested in vitro demonstrated the ability to uptake AHA (Fig.2), it is also expected that each species 
will incorporate AHA into new proteins at different rates. Similarly, it is possible that catabolism 
of AHA may skew bacterial composition or induce metabolic changes (61). Future work will be 
aimed at optimizing reaction conditions and incubation times to minimize the effect of the 
experimental approach biasing FACS and sequencing data. 
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 Despite these limitations, BONCAT can be used to extend our understanding of the role of 
specific microbiota in chronic lung disease. Here we focused on a cross-sectional cohort of stable 
CF subjects, but the approach can be used to address important questions about microbial 
community dynamics over time. For example, (i) how do active populations vary with disease 
state? Future studies will focus on longitudinal analyses of within-subject microbial dynamics and 
how active species correlate with disease symptoms. By identifying bacterial sub-populations most 
active either preceding or during an acute disease flare (i.e., PEx), more effective therapeutic 
strategies are likely to be identified. (ii) Why are only some subjects responsive to antimicrobial 
therapy? As mentioned above, in vivo drug efficacy is often inconsistent with clinical sensitivity 
panels. By obtaining sputum and amending small aliquots with different classes of antibiotics, 
BONCAT analysis of the ensuing changes in bacterial activity can be used to predict how CF 
subjects might respond to treatment. (iii) How do specific taxa respond to environmental stimuli? 
It is known that bacteria are dynamically responsive to their growth environment, yet how CF 
microbiota adapt to perturbations in the sputum milieu is poorly understood. BONCAT 
characterization of sputum samples amended with specific nutrients or incubation under varying 
environmental conditions (e.g., low pH) will help to shed light on parameters that constrain or 
potentiate bacterial growth in vivo. (iv) How is translational activity spatially arranged? With the 
exception of small bacterial aggregates (Fig.3), the approach described here offers limited insight 
on the spatial distribution of bacterial activity. As an alternative to FACS-based sequencing, 
BONCAT could be combined with species-specific fluorescence in situ hybridization (FISH) 
probes and histological analysis of sputum (or lung tissue) to visualize spatial relationships between 
translationally active bacteria (39,40,62). 
 In summary, we demonstrate that BONCAT is a powerful tool for the visualization and 
identification of translationally active bacteria and provides a measure of microbial activity not 
captured by conventional molecular profiling. Our use of BONCAT lays the foundation for a more 
detailed understanding of the ecophysiology of CF microbiota and has important implications for 
the development of new therapeutic strategies and improved clinical outcomes. In addition, the 
approach is broadly applicable to other airway diseases (e.g., COPD, ventilator associated 
pneumonias, and sinusitis) where the activity of complex bacterial communities is central to disease 
states. We are currently using this approach to study microbial community dynamics in a variety 




Bacterial strains and culture conditions 
 
 Bacterial strains are listed in Table 1. Fusobacterium nucleatum, Prevotella 
melaninogenica, Veillonella parvula, and Streptococcus parasanguinis were derived from the 
American Tissue Type Collection and obtained from Microbiologics (St. Cloud, MN). Rothia 
mucilaginosa was obtained from the Japan Collection of Microorganisms (Riken, Tokyo). 
Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa were obtained from D. K. 
Newman (California Institution of Technology), and Burkholderia cenocepacia was obtained from 
C.H. Mohr (University of Minnesota). Achromobacter xylosoxidans and Stenotrophomonas 
maltophilia were isolated from individuals undergoing treatment at the UMN Adult CF Center. 
Aerobes were maintained on Luria-Bertani (LB) agar, while anaerobes were maintained on Brain-
Heart Infusion (BHI) agar supplemented with a 5% vitamin K-hemin solution (Hardy Diagnostics 
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#Z237) in an anaerobic chamber (Coy) under a 90% N2/5% CO2/5% H2 atmosphere. Bacterial 
growth curves were performed in triplicate in BHI broth containing either 6 mM L-
azidohomoalanine (AHA) or 6 mM L-methionine (MET). 
 
Bioorthogonal non-canonical amino-acid tagging (BONCAT) 
 
 BONCAT labeling was performed as described by Hatzenpichler (40) with modifications. 
Briefly, for imaging of lab-grown cultures (see below), P. aeruginosa, B. cenocepacia, A. 
xylosoxidans, S. maltophilia, R. mucilaginosa, E. coli, and S. aureus were grown aerobically in LB, 
while S. parasanguinis, V. parvula, P. melaninogenica, and F. nucleatum were cultured under 
anaerobic conditions in BHI broth supplemented with hemin and vitamin K. Cultures were grown 
overnight and diluted 1/100 in 10 mL of fresh medium. Upon reaching mid-log phase, cultures 
were supplemented with either 6 mM AHA or 6 mM methionine (MET) and incubated for 3 h at 
37 °C. When indicated, an antibiotic cocktail consisting of chloramphenicol (30 µg mL−1), 
tetracycline (200 µg mL−1), and tobramycin (10 µg mL−1) was added 30 min prior to AHA addition 
to arrest protein synthesis. After incubation, cultures were pelleted via centrifugation (5 min at 
10,000 × g), fixed in 4% paraformaldehyde (PFA) for 2 h at 4 °C, resuspended in phosphate 
buffered saline (PBS, pH 7.4) and stored at 4 °C. All growth curves were performed in triplicate (n 
= 3). 
 Sputum samples used for imaging were treated with cycloheximide (100 µg mL−1) upon 
expectoration and divided into three equal volumes. Aliquots were supplemented with either AHA 
(6 mM), methionine (6 mM), or AHA (6 mM) with chloramphenicol/tetracycline/tobramycin as 
described above, incubated at 37 °C for 3 h, followed by fixation in 4% PFA overnight at 4 °C. 
Samples collected for flow cytometry were divided into five 300−500 µL aliquots. One control 
aliquot was immediately frozen at −80 °C and later used for conventional 16 S rRNA gene 
sequencing. Cycloheximide (100 µg mL−1) was added to the remaining four aliquots, three of which 
were supplemented with AHA (6 mM). One was also supplemented with MET (6 mM), followed 
by incubation of all samples at 37 °C for 3 h. Labeled samples (and unlabeled controls) were then 
fixed in 4% PFA for 2 h, pelleted via centrifugation (5 min at 10,000 × g), resuspended in PBS, and 




 For each bacterial culture and sputum sample, strain-promoted azide-alkyne cycloaddition 
(click chemistry)63 was also performed as described previously (40). Briefly, fixed biomass was 
pelleted, resuspended in freshly prepared 2chloroacetamide (100 mM) and incubated for 1 h at 46 
°C, shaking at 450 r.p.m. in the dark. Cy5-dibenzocyclooctyne (Cy5–DBCO) (Click Chemistry 
Tools) was then added to a final concentration of 10 µM followed by incubation for 30 min at 46 




 P. aeruginosa was grown to late-exponential phase as described above and supplemented 
with varying concentrations of AHA (100 µM–1 mM) for 1 h prior to fixation. Similarly, P. 
aeruginosa was grown in the presence of varying ratios of MET:AHA. Bacterial pellets were 
resuspended in extraction buffer (1% sodium dodecyl sulfate, 50 mM NaCl, 100 mM EDTA, 1 mM 
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MgCl2 at pH 8.4) and boiled for 30 min. After boiling, samples underwent click chemistry as 
described above. A mixture of methanol:chloroform:water (12:3:8) was then added to each sample 
followed immediately by centrifugation for 5 min at 16,000 × g. The water/ methanol phase was 
then carefully removed, and protein recovered from the interface was washed three times in 100% 
methanol. After the final wash, supernatant was removed and pellets were air dried. Protein was 
resuspended in 100 μl 1X LDS (lithium dodecyl sulfate) sample buffer and denatured at 70 °C for 
10 min. Ten microliter of protein was run on an 8% Bis-Tris gel with MOPS (3-(N-
morpholino)propanesulfonic acid)-sodium dodecyl sulfate (SDS) running buffer to which sodium 
bisulfite had been freshly added. Gels were run at 150 V, fixed for 30 min in a 1:2:7 
acetate:methanol:water mix, and imaged with a Typhoon FLA 9500 scanner (GE Healthcare) using 




 BONCAT-labeled bacterial cultures and sputum were spotted on Superfrost Plus 
microscope slides and counterstained using 1.6 µM STYO64 in PBS. Slides were then washed 
twice in PBS, mounted using Prolong Diamond Antifade and imaged using an Olympus IX83 
microscope with a transmitted Koehler illuminator and a ×60 oil objective lens (NA 1.42). Images 
were captured on a Hamamatsu ORCA-Flash4.0 V2 digital CMOS camera, and post-acquisition 
image analysis was performed using cellSens software (v.1.14, Olympus). SYTO64 and Cy5 were 
visualized using excitation/emission wavelengths of 562 nm/583 nm and 628/640 nm, respectively. 
 Image analysis was performed using FIJI (64). Briefly, images were subjected to 
background subtraction using a rolling ball radius of 150 pixels. Individual cells were identified by 
adjusting thresholds of SYTO64 images using Huang’s fuzzy thresholding method (65). Images 
were also segmented using a watershedding algorithm that assumes each maximum belongs to a 
discrete particle. The Analyze Particles operation was used to detect and record locations of 
individual bacterial cells in a given image. For clinical samples, particles were constrained between 
100 and 1000 pixels to minimize detection of host cells and sputum debris. Mean pixel intensity at 
647 nm (Cy5) was then quantified for each assigned particle. Imaging experiments were performed 
in triplicate for each bacterial species, and ten images for each sample were captured (n > 1000 




 Prior to sorting, Cy5–DBCO-labeled sputum was collected by centrifugation and 
counterstained with 1.6 µM SYTO9 (Invitrogen) in PBS for 30 min. Sputum samples were also 
stained with 1 µg ml−1 of phycoerythrin (PE) antihuman CD45RO in PBS (BioLegend) for 30 min 
to stain activated and memory T cells, some B-cell subsets, activated monocytes/macrophages, and 
granulocytes. All samples were washed in PBS containing 1% BSA and 1 mM EDTA, 
homogenized using 16- and 22-gauge needles and filtered through a 40 μm cell strainer. To separate 
AHA + and AHA- bacterial populations, clinical samples were analyzed and sorted on a 
FACSAriaIIu Cell Sorter (Beckton Dickinson) with a 70μm nozzle at 70 psi. Contaminating human 
leukocytes staining positive for PE antihuman CD45RO were excluded from bacterial populations 
of interest in the initial sorting gate (Supplementary Fig. 9). An AHA- control was then matched to 
each sample to determine the level of non-specific Cy5–DBCO binding and was used to establish 
Cy5+ (i.e., active) and Cy5− (i.e., inactive) sorting gates. Forward scatter and side scatter gates 
 
 154 
were then applied to remove large particulates and debris, and liberal doublet discrimination was 
used to minimize loss of bacterial aggregates. Collected samples were stored at 4 °C and processed 
within 24 h. FlowJo software (v.10.5.0) was used for data analysis and presentation. 
 Cy5+ and Cy5− sorted populations were assessed for post-sort purity by flow cytometry, 
while collected fractions were visualized by anti-Cy5 immunostaining. To do so, BONCAT-labeled 
sputum samples were spread across Superfrost Plus microscope slides using a sterile pipette tip and 
allowed to air dry for 30 min. Slides were washed 3X in PBS and blocked using 1% goat serum in 
PBS for 1 h, followed by treatment with an anti-Cy5 monoclonal antibody (C1117, Sigma–Aldrich) 
(1:100 dilution) in incubation buffer (1% goat serum, 0.3% Triton X100 and 10 mg mL−1 bovine 
serum albumin) overnight at 4 °C. Slides were washed 3×, and incubated with Cy3 goat anti-mouse 
secondary antibody (1:250) in incubation buffer for 45 min. Slides were washed 2×, counterstained 





 Genomic DNA (gDNA) was extracted using a modified phenolchloroform method 
previously described (66). Briefly, FACS-sorted samples were collected onto 0.22 µm 
polycarbonate membranes (EMD Millipore), which were then transferred to 1 mL of TENS buffer 
(50 mM Tris-HCl [pH 8.0], 20 mM EDTA, 100 mM NaCl, 1% SDS) containing lysozyme (0.2 mg 
mL−1) and lysostaphin (0.02 µg mL−1) and incubated at 37 °C for 30 min. Sodium dodecyl sulfate 
(SDS) and proteinase K were added to final concentrations of 1% and 1.2 mg mL−1, respectively, 
and samples were incubated overnight at 55 °C. Enzymes were deactivated by incubating samples 
at 90 °C for 30 min, and sample liquid (including membrane) was transferred to a 5 mL conical 
tube containing an equal volume of phenol:chloroform:isoamyl alcohol (P:C:I, 25:24:1, pH 7.9), 
which dissolved the membrane. The resulting sample was then split into two Lysing Matrix E tubes 
(MP Biomedicals) and processed twice by bead beating for 30 seconds. Contents of both tubes 
were recombined and centrifuged at 3200 × g for 20 min. The aqueous layer was transferred to a 
new tube and P:C:I extraction was repeated, followed by a chloroform:isoamyl alcohol (24:1) 
extraction. A 1/10th volume of sodium acetate (3 M, pH 5.2) was then added and nucleic acid was 
precipitated using one volume of isopropanol followed by centrifugation at 21,130 × g for 20 min. 
Supernatant was removed, the pellet was washed with 80% ethanol, and centrifuged at 21,130 × g 
for 10 min. Finally, the gDNA pellet was air dried, resuspended in 10 mM Tris buffer (pH 8.0), and 
stored at −80 °C until sequencing. 
 
DNA sequencing and analysis 
 
 gDNA derived from sputum samples was submitted to the University of Minnesota 
Genomics Center (UMGC) for 16 S rRNA gene library preparation using a two-step PCR protocol 
(67). The V4 variable region was amplified using V4_515F and V4_806R primers with common 
adapter sequences (5’-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAG 
CMGCCGCGGTAA-3’, 5’-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACA 
GGGACTACHVGGGTWTCTAAT-3’), followed by the addition of dual indices and Illumina 
flow cell adaptors in a secondary amplification using primers 5’-AAT 
GATACGGCGACCACCGAGATCTACACXXXXXXXXTCGTCGGCAGCGTC-3’ and 5’-
CAAGCAGAAGACGGCATACGAGATXXXXXXXXGTCTCGTGGGCT CGG-3’. Amplicons 
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were sequenced on an Illumina MiSeq using TruSeq (v.3) 2 × 300 paired-end technology. FACS 
sheath fluid and DNA extraction reagent control samples were also submitted for sequencing. These 
control samples did not pass quality control steps due to DNA content below detection thresholds 
but were incorporated into downstream analyses. An average of 67,793 sequences per sample were 
obtained. Sequence data are available at NCBI sequence read archive under Bioproject ID 
PRJNA604587. 
 Sequence quality was assessed using the DADA2 R package (v.1.2.1) (55). Cutadapt (68) 
was used to remove primer and Illumina adapter sequences, with size filtering set to a minimum 
and maximum of 215 bp and 285 bp, respectively. DADA2 functions were used to trim and filter 
sequences, model and correct Illumina sequence errors, align paired-end sequences, and filter 
chimeric reads. Specifically, forward and reverse sequences were trimmed to 250 bp and 200 bp, 
respectively, and a post-trimming minimum length filter of 175 bp was applied. All other DADA2 
pipeline parameters were run using default options. Resulting amplicon sequence variants (ASVs) 
were assigned taxonomy using RDP classifier (69) and the SILVA SSU database (Release 132, 
December 2017) (70,71). Species-level taxonomy was assigned using the DADA2 addSpecies 
function only if an ASV unambiguously matched a sequence in the SILVA-132 database. A 
phylogenetic tree was approximated using the phangorn R package (72) and sequences were 
aligned using DECIPHER. The phangorn package was then used to construct a neighbor-joining 
tree, which was then used to fit a GTR + G + I maximum likelihood tree. 
 The Decontam package (v.1.2.0) (73) was used to reproducibly filter out contaminant 
sequences. The function isContaminant was used with method = “either” and a probability 
threshold set to 0.5. Frequency was determined from 16 S qPCR data obtained from UMGC. A 
total of 28 taxa were removed from the dataset based on frequency and prevalence in the sample 
when compared with DNA extraction control. An average of 40,773 sequences were recovered 
from DADA2/Decontam analysis corresponding to 357 ASVs. 79.55% of ASVs were assigned to 
the genus level, and 22.97% had an unambiguous species assignment. 
 ASV count data, taxonomic assignment, and the phylogenetic tree were used within the 
analysis framework of the Phyloseq R package (v.1.26.0)(74–80). ASVs were filtered when they 
did not belong to the domain Bacteria, or when not assigned taxonomy at the phylum level. Phyla 
that had low prevalence and abundance (including Acidobacteria, Chloroflexi, Dependentiae, 
Planctomycetes, and Synergistetes) were removed from the dataset, as were singleton ASVs or 
those that did not belong to the original or input samples. Finally, ASVs at a relative abundance 
below 0.001 (0.1%) were removed. After filtering there remained 45 unique taxonomic assignments 
with 22 assigned at the species level. Fold-change in relative abundance for each ASV were 
calculated between sort input and sort-positive fractions for each study subject. For all figures, a 




 Raw 16 S rRNA gene sequence data (Fig. 5 and Supplementary Figs. 8, 11-13) that support 
the findings of this study were deposited and are available as fastq files in the NCBI sequence read 
archive under Bioproject ID PRJNA604587. Source data and full gel scans underlying Figs. 1, 3, 
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Table 1. Bacterial strains used in this study 
Bacterial Species Comment Source 
Achromobacter xylosoxidans CF clinical isolate MN001 75 
Burkholderia cenocepacia CF Clinical isolate K56-2 76 
Escherichia coli UQ950 77 
Fusobacterium nucleatum ATCC 25586 ATCC 




Rothia mucilaginosa JCM 10910 79 
Staphylococcus aureus Clinical isolate MN8 80 
Stenotrophomonas maltophilia CF clinical isolate CHB83-1 This study 
Streptococcus parasanguinis ATCC 15912 ATCC 









Figure 1. BONCAT labeling of P. aeruginosa differentiates translationally active and inactive 
cells. P. aeruginosa was incubated in the presence of a AHA, b methionine (MET), and c antibiotics 
prior to AHA (ABX). Actively growing cells were identified via strain-promoted click chemistry 
(Cy5, magenta; SYTO64, blue). Histograms associated with each image represent average Cy5 
pixel intensity (relative fluorescence units, RFU) per cell. d Two AHAtreated cultures (one with 
antibiotics, one without) were mixed in a 1:1 ratio prior to Cy5–DBCO labeling. These data 
demonstrate that BONCAT can differentiate translationally active and inactive bacterial cells in a 
complex nutritional milieu. Scale bar = 10 µm. n refers to the number of cells examined over ten 







Figure 2. BONCAT can identify active cells among diverse CF microbiota. Two cultures (one 
treated with antibiotics, one without) of each species were grown in the presence of AHA and 
mixed 1:1 prior to Cy5–DBCO (magenta) labeling and SYTO64 counterstaining (blue). These data 
demonstrate that BONCAT can differentiate between active and inactive bacterial cells among 
diverse CF microbiota. Scale bars; Ax, Bc, Fn, Ec, Pm, Rm = 20 µm; Sa, Sm, Sp = 10 µm; Vp = 5 
µm. Images are representative of ten images from each of three biologically independent 






Figure 3. CF microbiota exhibit heterogeneous translational activity within sputum. a Sputum 
was incubated in the presence of 6 mM AHA immediately upon expectoration. BONCAT labeling 
with Cy5–DBCO (magenta) and counterstaining with SYTO64 (blue) reveals heterogeneous AHA 
incorporation (i.e., translational activity). b Higher magnification images further emphasize the 
range of bacterial activity at the single-cell level. c Average Cy5 pixel intensity per cell suggests 
slow and heterogeneous translational activity among bacterial cells in situ. Scale bars; a = 100 µm, 





























































































































































































































































































































































Fig. 5 BONCAT, FACS, and sequencing of CF sputum reveals the taxonomic identities of 
translationally active microbiota. a FACS of BONCAT-labeled sputum reveals Cy5− and Cy5+ 
subpopulations. Percentages shown reflect % of parent population post-CD45RO gating. b 
Original, sort input, sortnegative (Cy5−), and sort-positive (Cy5+) fractions were analyzed by 16 
S rRNA gene sequencing. Taxa plots summarize sequencing data by subject and averaged relative 
abundances between triplicate-positive and -negative sorted fractions. c Fold-changes between 
relative abundances of taxa in the sortpositive compared to the negative fraction. Point color 
indicates taxa that were increased (pink) and decreased (blue) in relative abundance in the 
sortpositive fraction, representing translationally active microbiota. The single gray points indicate 









Figure S1. BONCAT labeling of P. aeruginosa is specific for AHA and translational activity. 
SDSPAGE visualization of BONCAT labeling of laboratory cultures of P. aeruginosa PA14. 
Labeling is specific for AHA and inhibited by antibiotics (Abx = chloramphenicol, tetracycline, 






Figure S2. AHA-incubation has negligible effect on bacterial growth. Growth curves were 
performed in triplicate for each species under each growth condition (6mM L-azidohomoalanine 
(AHA) or 6mM methionine (MET)). Error bars represent standard deviation of the mean of three 






Figure S3. Cycloheximide Inhibition of host cell BONCAT labeling. RAW 264.7 macrophages 
(Sigma Aldrich 91062702) were cultured in T25 flasks containing high glucose Dulbecco’s 
Modified Eagle’s Medium supplemented with GlutaMAX and pyruvate (Thermo, 10569044). 
Cycloheximide was added to one flask at a final concentration of 100 µg/mL, and another was left 
untreated. AHA was then added to a final concentration of 6mM to both flasks and incubated for 
3h. Cells were detached using 0.25% trypsin solution in EDTA (Sigma T4049) and fixed in 1mL 
of 4% PFA in PBS for 2 h prior to imaging. Imaging was performed as described in the main text. 
Representative images of two biologically independent experiments are shown. (a) BONCAT 
labeling of macrophages to which cycloheximide was added were inhibited relative to (b) untreated 






Figure S4. Supplementary Figure 4. SDS-PAGE determination of MET:AHA ratio required for 
BONCAT labeling of P. aeruginosa. Cells were grown in varying concentrations of MET:AHA 
prior to labeling with Cy5-DBCO. Based on these profiles, a 1:10 ratio was selected for labeling of 
in vitro bacterial cultures and expectorated sputum samples. These data are representative of three 






Figure S5. BONCAT labeling of sputum microbiota is specific for AHA. Expectorated sputum 
samples were supplemented with 6mM AHA and incubated for 3h prior to Cy5-DBCO labeling 
(Cy5; magenta) and counterstaining (SYTO64; blue). Negligible background fluorescence was 
observed in paired sputum samples incubated with methionine (MET). Incubation with antibiotics 
prior to AHA labeling (ABX+AHA) resulted in a moderate decrease in fluorescence that may 
reflect antimicrobial tolerance among airway microbiota. Bar = 100 µm. Abx = chloramphenicol, 






Figure S6. Supplementary Figure 6. Validation of BONCAT-FACS. During sorting, the Cy5 label 
is subject to photobleaching; we therefore used immunostaining (Cy3 anti-Cy5 antibody), 
fluorescence microscopy and quantitative image analysis in FIJI to validate FACS sort integrity. 
Pixel intensity was calculated as described in Methods. Anti-Cy5 labeling of sort input, sort 
negative and sort positive fractions demonstrates that BONCAT-FACS effectively removes host 
cells and translationally inactive bacteria from downstream 16S rRNA gene sequencing analysis. 
As expected, more cells in the positive fraction were anti-Cy5 reactive, confirming AHA uptake 
and translational activity among this bacterial subpopulation. However, some collected cells 
appeared unlabeled by the Cy3-labeled antibody. If we assume a mean pixel intensity of 10,000 as 
the cutoff between AHA-/AHA+ cells, these data suggest false negative and false positive sort rates 






Figure S7. FACS of BONCAT-labeled sputum reveals consistency of Cy5- and Cy5+ 
subpopulations between replicates. Percentages shown reflect % of parent population post-






Figure S8. 16s rRNA gene sequencing reveals concordance of sort positive and sort negative 
replicates. (a) Stacked bar graphs of taxa relative abundance including all samples in analysis 
(triplicate positive and negative sort). (b) Double Principle Coordinate Analysis (DPCoA) shows 





Figure S9. Representative gating scheme for AHA+ and AHA- populations. (a) AHA- control 
samples were first gated based on PE anti-human CD45RO staining to remove human leukocytes. 
Next, the negative control was used to measure background Cy5 fluorescence to define Cy5+ (i.e. 
active) and Cy5- (i.e. inactive) sorting gates. (b) shows a subject-matched AHA+ sample and the 
gating used to isolate populations of interest. The gating strategy involved, i) excluding human 
leukocytes using PE anti-human CD45RO, ii) using Cy5+ and Cy5- gates based on the subject-
matched AHA- control, iii) creating forward scatter and side scatter plots to remove large, complex 
particulates and debris, and liberal doublet discrimination to minimize the loss of bacterial 







Figure S10. Confirmation of BONCAT Labeling. Flow cytometry histograms represent the 
number of events (cell counts) versus the log fluorescent intensity of Cy5 (blue = Cy5- population, 
magenta = Cy5+ population). Numbers in the upper left-hand corner represent the geometric means 
of Cy5 intensity. The Cy5+ population exhibited a higher geometric mean of fluorescent intensity 







Figure S11. Low abundance community members are translationally active. Bacterial community 
membership of taxa with relative abundances less than 10% exhibit notable differences between 
“sort positive” community composition (i.e. translational activity) relative to the “original” 
fraction.  






































































































































































































































Figure S12. Fold difference in taxon relative abundance between “sort input” and “sort positive” 
fractions. Pink and black markers indicate taxa that were higher in relative abundance in the positive 
and input fractions, respectively. Source data are provided as a Source Data file. 
  


































































































































































Figure S13. . Fold difference in taxon relative abundance between “sort input” and “sort negative” 
fractions. Black and blue markers indicate taxa that were higher in relative abundance in the input 



































































































































































Table S1. Cohort clinical data 
Subject Age Sex FEV1% 
CFTR 
genotype 
Bacterial Cultures Current Antibiotics 
1 23 F 38 ∆F508/∆F508 A. xylosoxidans 
azithromycin, colistin, 
doxycycline 
2 38 M 31 ∆F508/∆F508 
A. xylosoxidans,  







3 23 M 56 ∆F508/∆I507 




4 26 F 42 
∆F508/N1303
K 
S. aureus,  









































Table S2. BONCAT-FACS summary 
Subject Replicate 





























 1 1,632,712 4,000,000 7.2 57.4 1047 4514 
4 2 3,061,496 4,010,359 11.2 45.9 1057 4605 
 3 1,329,894 4,000,000 5.5 64.9 1026 4345 
 1 1,983,509 4,001,293 22.5 43.2 1010 4738 
5 2 2,770,068 4,003,957 21.5 47.9 1744 5535 
 3 4,000,000 4,003,615 32.6 36.7 970 5352 
 1 4,000,000 2,144,345 51.8 6 565 3138 
6 2 4,000,000 3,845,123 55.3 7.5 626 3035 
 3 4,000,000 1,717,276 53.1 5.1 583 2693 
 
a Percentages reflect % of parent population post-CD45RO gating. Remaining counts fell 
outside Cy5-/Cy5+ gates.  
b Histograms are shown in Supplementary Figure 8. 
